|
| |
List of Publications Using Islets From ICR
|
| |
Below
is a list of publications representing the work
supported, in part, by funding from the National
Islet Cell Resource Program. PUBMED Abstracts of
the articles are available below. All
articles are ordered by year of publication and
alphabetically by author's last name. |
| |
| |
2009 |
| |
|
|
| |
1. |
Asari
S, Itakura S, Ferreri K, Liu CP, Kuroda Y, Kandeel F, Mullen Y: Mesenchymal stem
cells suppress B-cell terminal differentiation. Exp Hematol. 2009 May; 37(5): 604-15.
[PUBMED] |
| |
| |
2. |
Balamurugan
AN, Akhov L, Selvaraj G, Pugazhenthi S: Induction of antioxidant enzymes by curcumin
and its analogues in human islets: Implications in transplantation. Pancreas Vol 00,
(00) Published Ahead of Print, 2 Feb 2009
[PUBMED] |
| |
| |
3. |
Chen
H, Gu X, Su IH, Bottino R, Contreras JL, Tarakhovsky A, Kim SK: Polycomb protein
Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes
mellitus. Genes & Dev. 2009 Apr 15; 23(8):975-85
[PUBMED] |
| |
| |
4. |
Correa-Medina
M, Bravo-Egana V, Rosero S, Ricordi C, Edlund H, Diez J, and Pastori RL: MicroRNA miR-7
is preferentially expressed in endocrine cells of the developing and adult human pancreas.
Gene Expr Patterns. 2009 Apr;9 (4):193-9. Epub 2008 Dec 24.
[PUBMED] |
| |
| |
5. |
Dhawan
S, Tschen SI, Bhushan A: Bmi-1 regulates the Ink4a/Arf locus to control pancreatic
beta-cell proliferation. Genes Dev. 2009 Apr 15;23(8):906-11.
[PUBMED] |
| |
| |
6. |
Fiaschi-Taesch
N, Bigatel TA, Sicari B, Takane KK, Salim F, Velazquez-Garcia S, Harb G, Selk K, Cozar-Castellano
I, Stewart AF: Survey of the Human Pancreatic Beta Cell G1/S Proteome Reveals a Potential
Therapeutic Role for Cdk-6 and Cyclin D1 in Enhancing Human Beta Cell Replication and Function
in Vivo. Diabetes, 2009 Apr;58(4):882-93. Epub 2009 Jan 9.
[PUBMED] |
| |
| |
7. |
Glas
R, Sauter NS, Schulthess FT, Shu L, Oberholzer J, Maedler K: Purinergic P2X7 receptors
regulate secretion of interleukin-1 receptor antagonist and beta cell function and survival.
Diabetologia 2009 Aug;52(8):1579-88. Epub 2009 Apr 25
[PUBMED] |
| |
| |
8. |
Huang
J, Levitsky LL, Rhoads DB: Novel P2 Promoter-Derived HNF4α Isoforms with Different
N-Terminus Generated by Alternate Exon Insertion. Exp Cell Res. 2009 Apr 15;315(7):1200-11
[PUBMED] |
| |
| |
9. |
Ichii
H, Ricordi C: Current status of islet cell transplantation. J Hepatobiliary Pancreat
Surg. 2009;16(2):101-12. Epub 2008 Dec 26
[PUBMED] |
| |
| |
10. |
Kaddis
J, Olack B, Sowinski J, Cravens J, Contreras J, Niland J. Human Pancreatic
Islets and Diabetes Research. JAMA. 2009;301(15):1580-1587
[PUBMED
abstract] |
| |
| |
11. |
Lee
SH, Hao E, Savinov AY, Geron I, Strongin AY, Itkin-Ansari P: Human [beta]-cell
precursors mature into functional insulin-producing cells in an immunoisolation
device: implications for diabetes cell therapies. Transplantation. 2009 Apr 15;87
(7):983-91
[PUBMED] |
| |
| |
12. |
Liu
H, Remedi MS, Pappan KL, Kwon G, Rohatgi N, Marshall CA, McDaniel ML. Both
Glycogen Synthase Kinase-3 (GSK-3) and Mammalian Target of Rapamycin (mTOR)
Pathways Contribute to DNA Synthesis, Cell Cycle Progression and Proliferation
in Human Islets. 2009 Mar;58(3):663-72. Epub 2008 Dec 10
[PUBMED
abstract] |
| |
| |
13. |
Liu
S, Le May C, Wong WP, Ward RD, Clegg DJ, Marcelli M, Korach KS, Mauvais-Jarvis
F: Importance of extranuclear estrogen receptor-{alpha} and membrane G protein-coupled
estrogen receptor in pancreatic islet survival. Diabetes. 2009 Jul 8. [Epub ahead of print]
[PUBMED] |
| |
| |
14. |
Mohammed
JS, Wang Y, Harvat TA, Oberholzer J, Eddington DT: Microfluidic device for multimodal
characterization of pancreatic islets. Lab Chip. 2009 Jan 7;9(1):97-106. Epub 2008 Oct 21.
[PUBMED] |
| |
| |
15. |
Mulla
CM, Geras-Raaka E, Raaka BM, Gershengorn MC: High levels of thyrotropin-releasing
hormone receptors activate programmed cell death in human pancreatic precursors.
Pancreas 2009 Mar. 38(2)197-202.
[PUBMED] |
| |
| |
16. |
Panakanti
R, Mahato RI: Bipartite adenoviral vector encoding hHGF and hIL-1Ra for improved
human islet transplantation. Pharm Res. 2009 Mar;26(3):587-96. Epub 2008 Nov 12.
[PUBMED] |
| |
| |
17. |
Panakanti
R, Mahato RI: Bipartite Vector Encoding hVEGF and hIL-1Ra for Ex Vivo Transduction
into Human Islets. Mol Pharm. 2009 Jan-Feb; 6(1): 274-84.
[PUBMED] |
| |
| |
18. |
Qi
M, Barbaro B, Wang S, Wang Y, Hansen M, Oberholzer J: Human pancreatic islet
isolation: Part I: digestion and collection of pancreatic tissue. J Vis Exp.
2009 May 26;(27). pii: 1125. doi: 10.3791/1125
[PUBMED] |
| |
| |
19. |
Qi
M, Barbaro B, Wang S, Wang Y, Hansen M, Oberholzer J: Human pancreatic islet
isolation: Part II: purification and culture of human islets. J Vis Exp. 2009
May 26;(27). pii: 1343. doi: 10.3791/1343
[PUBMED] |
| |
| |
20. |
Russ
HA, Ravassard P, Kerr-Conte J, Pattou F, Efrat S: Epithelial-mesenchymal transition
in cells expanded in vitro from lineage-traced adult human pancreatic Beta cells.
PLoS One. 2009 Jul 29;4(7):e6417
[PUBMED] |
| |
| |
21. |
Sarkar
SA, Kutlu B, Velmurugan K, Kizaka-Kondoh S, Lee CE, Wong R, Valentine A, Davidson HW,
Hutton JC, Pugazhenthi S: Cytokine-mediated induction of anti-apoptotic genes that are
linked to nuclear factor kappa-B (NF-κB) signaling in human islets and in a mouse beta
cell line. Diabetologia. 2009 Jun;52(6):1092-101. Epub 2009 Apr 3.
[PUBMED] |
| |
| |
22. |
Schulthess
FT, Paroni F, Sauter NS, Shu L, Ribaux P, Haataja L, Strieter RM, Oberholzer J, King
CC, Maedler K: CXCL10 impairs β-cell function and viability in diabetes through
TLR4 signaling. Cell Metab. 2009 Feb;9(2):125-39.
[PUBMED] |
| |
| |
23. |
Shu
L, Matveyenko AV, Kerr-Conte J, Cho JH, McIntosh CH, Maedler K: Decreased TCF7L2
protein levels in type 2 diabetes mellitus correlate with downregulation of
GIP- and GLP-1 receptors and impaired beta-cell function. Hum Mol Genet. 2009
Jul 1;18(13):2388-99. Epub 2009 Apr 21
[PUBMED] |
| |
| |
24. |
Yu
J, Steck AK, Babu S, Yu L, Miao D, McFann K, Hutton J, Eisenbarth GS, Klingensmith
G. Single nucleotide transcription factor 7-like 2 (TCF7L2) gene polymorphisms in
antiislet autoantibody-negative patients at onset of diabetes. J Clin Endocrinol Metab.
2009 Feb; 94(2):504-10. Epub 2008 Dec 2.
[PUBMED
abstract] |
| |
| |
25. |
Zhang
S, Carper MJ, Lei X, Cade WT, Yarasheski KE, Ramanadham S: Protease inhibitors
used in the treatmentof HIV induce β-cell apoptosis via the mitochondrial pathway
and compromise insulin secretion. Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E925-35. Epub 2009 Feb 10
[PUBMED] |
| |
| |
2008 |
| |
|
|
| |
26. |
Al-Abdullah
IH, Bentsi-Barnes K, Valiente L, et al. Testing Combinations
of Protease Inhibitor and Preservation Solution to Improve
Islet Quality and Yield. Transplantation Proceedings 2008.
40, 390-392.
[PUBMED
abstract] |
| |
| |
27. |
Alejandro
R, Barton FB, Hering BJ, Wease S; Collaborative Islet Transplant Registry Investigators:
2008 Update from the Collaborative Islet Transplant Registry. Transplantation. 2008
Dec 27;86(12):1783-8
[PUBMED] |
| |
| |
28. |
Avgoustiniatos
ES, Hering BJ, Rozak PR, Wilson JR, Tempelman LA, Balamurugan
AN, Welch DP, Weegman BP, Suszynski TM and Papas KK:
Commercially available gas-permeable cell culture bags may
not prevent anoxia in cultured or shipped islets. Transplant
Proc. 2008 Mar;40(2):395-400.
[PUBMED
abstract] |
| |
| |
29. |
Bar
Y, Russ HA, Knoller S, Ouziel-Yahalom L, Efrat S: HES-1 is involved in adaptation
of adult human β-Cells to proliferation in vitro. Diabetes. 2008 Sep;57(9):2413-20.
Epub 2008 Jul 3.
[PUBMED] |
| |
|
|
| |
30. |
Bentsi-Barnes
K, Kandeel F, Al-Abdullah IH. Evaluation of Human Islet-
Specific Functional Quality Cultured on Different Gas-
Permeable Membranes. Transplantation Proceedings 2008.
40, 401-402.
[PUBMED
abstract] |
| |
|
|
| |
31. |
Bravo-Egana
V, Rosero S, Molano RD, Pileggi A, Ricordi C, Dom�nguez-Bendala
J, Pastori RL: Quantitative differential expression analysis
reveals miR-7 as major islet microRNA. Biochem Biophys Res
Commun 2008. 366(4):922-6. Epub 2007 Dec 18.
[PUBMED
abstract] |
| |
|
|
| |
32. |
Brissova
M, Powers AC. Revascularization of Transplanted Islets: Can It Be Improved? Diabetes 57:
2269, 2008.
[PUBMED
abstract] |
| |
|
|
| |
33. |
Brun
T, He KH, Lupi R, Boehm B, Wojtusciszyn A, Sauter N, Donath
M, Marchetti P, Maedler K, Gauthier BR: The diabetes-linked
transcription factor Pax4 is expressed in human pancreatic
islets and is activated by mitogens and GLP-1. Hum Mol Genet
2008. 17(4):478-89. Epub 2007 Nov 7.
[PUBMED
abstract] |
| |
|
|
| |
34. |
Cabrera
O, Jacques-Silva MC, Speier S, Yang S-N, Kohler M, Fachado A, Vieira E, Zierath JR,
Kibbey R, Berman DM, Kenyon NS, Ricordi C, Caicedo A, Berggren PO: Glutamate Is a
Positive Autocrine Signal for Glucagon Release. Cell Metab 7, 545-554; Jun 2008.
[PUBMED] |
| |
| |
35. |
Cabrera
O, Jacques-Silva MC, Berman DM, Fachado A, Echeverri F, Poo R, Khan A, Kenyon NS,
Ricordi C, Berggren PO, Caicedo A: Automated, high-throughput assays for evaluation
of human pancreatic islet function. Cell Transplant. 2008;16(10):1039-48.
[PUBMED] |
| |
| |
36. |
Chambers
KT, Unverferth JA, Weber SM, Wek RC, Urano F, Corbett JA: The role of nitric oxide and
the unfolded protein response in cytokine-induced beta-cell death. Diabetes. 2008 Jan;
57(1):124-32.
[PUBMED] |
| |
| |
37. |
Cheng
G, Zhu L, Mahato RI: Caspase-3 Gene Silencing for Inhibiting Apoptosis in Insulinoma
Cells and Human Islets. Mol Pharm. 2008 Nov-Dec;5(6):1093-102.
[PUBMED] |
| |
| |
38. |
Cozar-Castellano
I, Harb G, Selk K, Takane K, Vasavada R, Sicari B, Law B, Zhang P, Scott DK, Fiaschi-Taesch
N, Stewart AF: Lessons from the first comprehensive molecular characterization of cell cycle
control in rodent insulinoma cell lines. Diabetes, 2008 Nov;57(11):3056-68. Epub 2008 Jul 23
[PUBMED] |
| |
| |
39. |
Deshet
N, Lupu-Meiri M, Espinoza I, Fili O, Shapira Y, Lupu R, Gershengorn MC, Oron Y:
Plasminogen-induced aggregation of PANC-1 cells requires conversion to plasmin
and is inhibited by endogenous plasminogen activator inhibitor-1. J. Cell. Physiol.
216: 632-639. 2008
[Wiley] |
| |
| |
40. |
Dorrell
C, Abraham SL, Lanxon-Cookson KM, Canaday PS, Streeter PR, Grompe M: Isolation of
major pancreatic cell types and long-term culture-initiating cells using novel
human surface markers. Stem Cell Res. 2008 Sep;1(3):183-94. Epub 2008 May 8
[PubMed] |
| |
| |
41. |
Efrat
S: Ex-vivo Expansion of Adult Human Pancreatic Beta-Cells. Rev Diabet Stud.
2008 Summer;5(2):116-22. Epub 2008 Aug 10.
[PUBMED
abstract] |
| |
|
|
| |
42. |
Evgenov
NV, Pratt J, Pantazopoulos P, Moore A: Effects of Glucose
Toxicity and Islet Purity on In Vivo Magnetic Resonance
Imaging of Transplanted Pancreatic Islets.
Transplantation 2008;85: 1091-1098.
[PUBMED
abstract] |
| |
|
|
| |
43. |
Fornoni
A, Pileggi A, Molano RD, Sanabria NY, Tejada T, Gonzalez-Quintana J, Ichii H,
Inverardi L, Ricordi C, Pastori RL: Inhibition of c-jun N terminal kinase (JNK)
improves functional beta cell mass in human islets and leads to AKT and glycogen
synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 2008 Feb; 51(2): 298-308.
Epub Dec 8.
[PUBMED] |
| |
| |
44. |
Gangemi
A, Salehi P, Hatipoglu B, Martellotto J, Barbaro B, Kuechle JB, Qi M, Wang Y, Pallan
P, Owens C, Bui J, West D, Kaplan B, Benedetti E, Oberholzer J. Islet transplantation
for brittle type 1 diabetes: the UIC protocol. Am J Transplant. 2008 Jun;8(6):1250-61.
[PUBMED
abstract] |
| |
|
|
| |
45. |
Huang
J, Karakucuk V, Levitsky LL and Rhoads DB. Expression of
HNF4a variants in pancreatic islets and Ins-1 b cells.
Diabetes Metab Res Rev 2008 [Epub ahead of print: June
17; DOI: 10.1002/dmrr.870]
[PUBMED
abstract] |
| |
|
|
| |
46. |
Ichii
H, Miki A, Yamamoto T, Molano RD, Barker S, Mita A, Rodriguez-Diaz R, Klein D, Pastori
R, Alejandro R, Inverardi L, Pileggi A, Ricordi C: Characterization of pancreatic
ductal cells in human islet preparations. Lab Invest. 2008 Sep 8.
[Epub ahead of
print]
[PUBMED
abstract] |
| |
|
|
| |
47. |
Iglesias
I, Bentsi-Barnes K, Umeadi C, Brown L, Kandeel F, Al-Abdulla
IH. Comprehensive Analysis of Human Pancreatic Islets Using
Flow and Laser Scanning Cytometry. Transplantation Proceedings
2008. 40, 351-354
[PUBMED
abstract] |
| |
|
|
| |
48. |
Ikonomou
L, Geras-Raaka E, Raaka BM, Gershengorn MC. Beta-catenin
signaling in mesenchymal islet-derived precursor cells.
Cell Proliferation 2008. 41:474.
[PUBMED
abstract] |
| |
|
|
| |
49. |
Ito
T, Omori K, Rawson J, Todorov I, Asari S, Kuroda A, Shintaku J, Itakura S,
Ferreri K, Kandeel F, Mullen Y. Improvement of canine islet yield by donor
pancreas infusion with a p38MAPK inhibitor. Transplantation. 2008 Jul 27;
86(2): 321-9.
[PUBMED
abstract] |
| |
|
|
| |
50. |
Jayaraman
S: A novel method for the detection of viable human pancreatic beta cells by flow
cytometry using fluorophores that selectively detect labile zinc, mitochondrial
membrane potential and protein thiols. Cytometry A. 2008 Jul;73(7):615-25.PMID: 18412218
[PUBMED] |
| |
| |
51. |
Jewell
JL, Luo W, Oh E, Wang Z, Thurmond DC. Filamentous actin
regulates insulin exocytosis through direct interaction
with Syntaxin 4. J Biol Chem 2008. 283:10716-10726.
PMID: 18285343
[Full
text] |
| |
|
|
| |
52. |
Juhl
K, Sarkar SA, Wong R, Jensen J, Hutton JC: The mouse pancreatic endocrine cell
transcriptome defined in the embryonic Ngn3 null mouse. Diabetes. 2008 Jul 3.
[PUBMED
abstract] |
| |
|
|
| |
53. |
Kang
G, Leech CA, Chepurny OG, Coetzee WA, Holz GG: Role of
the cAMP sensor Epac as a determinant of KATP channel
ATP sensitivity in human pancreatic beta-cells and rat
INS-1 cells. J Physiol 2008. 586(5):1307-19. Epub 2008
Jan 17.
[PUBMED
abstract] |
| |
|
|
| |
54. |
King
M, Pearson T, Rossini AA, Shultz LD, Greiner DL: Humanized mice for the study
of type 1 diabetes and beta cell function. Ann NY Acad Sci 2008 Dec; 1150: 46-53
[PUBMED] |
| |
| |
55. |
King
MT, Pearson LD, Shultz JL, Bottino M, Trucco, Atkinson MA,
Wasserfall C, Herold KC, Woodland RT, Schmidt MR, Woda BA,
Thompson MJ, Rossini AA, Greiner DL. A new Hu-PBL model
for the study of human islet alloreactivity based on NOD-scid
mice bearing a targeted mutation in the IL 2 receptor gamma
chain gene. Clinical Immunology 2008. 126:303-314.
[PUBMED
abstract] |
| |
|
|
| |
56. |
Klein
D, Timoneri F, Ichii H, Ricordi C, Pastori RL. CD40 Activation in Human Pancreatic
Islets and Ductal Cells. Diabetologia. 2008 Jul 26.
[PUBMED
abstract] |
| |
|
|
| |
57. |
Lavine
JA, Raess PW, Davis DB, Rabaglia ME, Presley BK, Keller MP, Beinfeld MC, Kopin
AS, Newgard CB, Attie AD. Overexpression of pre-pro-cholecystokinin stimulates
{beta}-cell proliferation in mouse and human islets with retention of islet function.
Mol Endocrinol. 2008 Oct 9.
[PUBMED
abstract] |
| |
|
|
| |
58. |
Lee
S-H, Demeterco C, Geron I, Abrahamsson A, Levine F, Itkin-Ansari P: Islet
specific Wnt activation in human type II diabetes. Exp Diabetes Res. 2008;
728-763.
[PUBMED] |
| |
| |
59. |
Leitao
CB, Tharavanij T, Cure P, Pileggi A, Baidal DA, Ricordi C, Alejandro R. Restoration
of Hypoglycemia Awareness after Islet Transplantation. Diabetes Care. 2008 Aug 12.
[PUBMED
abstract] |
| |
|
|
| |
60. |
Li
F, Mahato RI: iNOS gene silencing prevents inflammatory
cytokine-induced beta-cell apoptosis. Mol Pharm 2008
May-Jun;5(3):407-17. Epub 2008 Jan 25.
[PUBMED
abstract] |
| |
|
|
| |
61. |
Li
N, Zhao D, Kirschbaum M, Zhang C, Lin CL, Todorov I, Kandeel
F, Forman S, Zeng D. HDAC inhibitor reduces cytokine storm
and facilitates induction of chimerism that reverses lupus
in anti-CD3 conditioning regimen. Proc Natl Acad Sci U S A
105, 4796-4801, 2008.
[PUBMED
abstract] |
| |
|
|
| |
62. |
Li
Y, Maedler K, Shu L, Haataja L. UCP-2 and UCP-3 proteins are
differentially regulated in pancreatic beta-cells. PLoS
ONE. 2008 Jan 2; 3(1):e1397.
[PUBMED
abstract] |
| |
|
|
| |
63. |
Linetsky
E, Ricordi C. Regulatory challenges in manufacturing of pancreatic islets. Transplant
Proc. 2008 Mar;40(2):424-6.
[PUBMED
abstract] |
| |
|
|
| |
64. |
Luo
L, Fang X, Ricordi C, Luo J: Human Islet Longevity: A New Approach with Allogeneic
Bone Marrow. 2008 Diabetes 57:Suppl.1 1596-P, A446
|
| |
| |
65. |
Marselli
L, Thorne J, Ahn YB, Omer A, Sgroi DC, Libermann T, Otu HH, Sharma A, Bonner-Weir S,
Weir GC. Gene expression of purified beta-cell tissue obtained from human pancreas with
laser capture microdissection. J Clin Endocrinol Metab. 2008 Mar;93(3):1046-53.
[PUBMED
abstract] |
| |
|
|
| |
66. |
Mathew
JM, Blomberg B, Ricordi C, Esquenazi V, Miller J. Evaluation of the tolerogenic effects
of donor bone marrow cells using a severe combined immunodeficient mouse-human islet
transplant model. Hum Immunol. 2008 Aug 11 [Epub ahead of print].
[PUBMED
abstract] |
| |
|
|
| |
67. |
Mehrabian
M, Schulthess FT, Nebohacova M, Castellani LW, Zhou Z, Hartiala J, Oberholzer J,
Lusis AJ, Maedler K, Allayee H. Identification of ALOX5 as a gene regulating
adiposity and pancreatic function. Diabetologia. 2008 Jun;51(6):978-88.
[PUBMED
abstract] |
| |
|
|
| |
68. |
Miki
A, Ricordi C, Yamamoto T, Mita A, Barker S, Khan A, Alejandro R, Ichii H: Effect
of Human Islet Rescue Gradient Purification on Islet Yield and Fractional Beta Cell
Viability. Transplant Proc. 2008 Mar;40(2):360-1.
[PUBMED
abstract] |
| |
|
|
| |
69. |
Parnaud
G, Bosco D, Berney T, Pattou F, Kerr-Conte J, Donath MY, Bruun C, Mandrup-Poulsen
T, Billestrup N, Halban PA. Proliferation of sorted human and rat beta cells.
Diabetologia. 2008 Jan;51(1):91-100.
[PUBMED
abstract] |
| |
|
|
| |
70. |
Pearson
T, Shultz LD, Leif J, Burzenski L, Gott B, Chase T, Foreman O, Rossini AA, Bottino R,
Trucco M, Greiner DL: A new immunodeficient hyperglycemic mouse model based on the
Ins2Akita mutation for analyses of human islet and beta stem and progenitor cell function.
Diabetologia. 2008 Aug;51(8):1449-56. Epub 2008 Jun 19.
[PUBMED
abstract] |
| |
|
|
| |
71. |
Poitout
V, Robertson RP. Glucolipotoxicity: Fuel excess and beta-cell
dysfunction. Endocr Rev 2008. 29(3):351-66. Epub 2007 Nov 29
[PUBMED
abstract] |
| |
|
|
| |
72. |
Powers
AC. Insulin Therapy versus Cell-Based Therapy for Type 1 Diabetes -
What is ahead? Nature Clinical Practice Endocrinology & Metabolism,
in press, 2008
[PUBMED
abstract] |
| |
|
|
| |
73. |
Robertson
RP. Metabolic measures of islet function and mass after
islet transplantation. In. Islet transplantation and beta-cell
replacement therapy. Eds. Shaw J, Ricordi C, Lakey J,
Shapiro J. In press.
|
| |
|
|
| |
74. |
Robertson
RP. Beta-cell replacement: pancreas and islet transplantation.
In Type 1 diabetes in adults: principle and practice. Eds.
Jabbour S, Hirsch I, Garg S, Stephens EZ, Goldstein BJ,
Riddle M. 2008 In press
|
| |
|
|
| |
75. |
Rozak
PR, Weegman B, Avgoustiniatos ES, Wilson JR, Welch DP, Hering
BJ, Papas KK: Devices and methods for maintenance of temperature
and pressure during islet shipment. Transplant Proc. 2008 Mar;40(2):407-10.
[PUBMED
abstract] |
| |
|
|
| |
76. |
Sakuma
Y, Ricordi C, Miki A, Yamamoto T, Pileggi A, Khan A, Alejandro R,
Inverardi L, Ichii H: Factors That Affect Human Islet Isolation.
Transplant Proc. 2008 Mar;40(2):343-5.
[PUBMED
abstract] |
| |
|
|
| |
77. |
Shu
L, Sauter NS, Schulthess FT, Matveyenko AV, Oberholzer J,
Maedler K. Transcription factor 7-like 2 regulates beta-cell
survival and function in human pancreatic islets. Diabetes.
2008 Mar;57(3):645-53. Epub 2007 Dec 10. PMID: 18071026
Full Text Diabetes |
| |
|
|
| |
78. |
Stanojevic
V, Habener JF, Holz GG, Leech CA: Cytosolic adenylate kinases
regulate K-ATP channel activity in human beta-cells. Biochem
Biophys Res Commun 2008. 368(3):614-9. Epub 2008 Feb 1.
[PUBMED
abstract] |
| |
|
|
| |
79. |
Suckow
AT, Comoletti D, Waldrop MA, Mosedale M, Egodage S, Taylor P, Chessler SD.
Expression of neurexin, neuroligin and their cytoplasmic binding partners in
the pancreatic {beta}-cells and the involvement of neuroligin in insulin secretion.
Endocrinology 149 (12): 6006-6017, Dec. 2008
[PUBMED
abstract] |
| |
|
|
| |
80. |
Suszynski
TM, Wildey GM, Falde EJ, Cline GW, Maynard KS, Ko N, Sotiris J,
Naji A, Hering BJ, Papas KK: The ATP/DNA Ratio Is a Better
Indicator of Islet Cell Viability Than the ADP/ATP Ratio.
Transplant Proc. 2008 Mar;40(2):346-50.
[PUBMED
abstract] |
| |
|
|
| |
81. |
Sweet
IR, Gilbert M, Scott S, Todorov I, Jensen R, Nair I, Al-Abdullah I, Rawson J,
Kandeel F, Ferreri K: Glucose-stimulated increment in oxygen consumption rate
as a standardized test of human islet quality. Am J Transplant. 2008
Jan;8(1):183-92. Epub 2007 Nov 12.
[PUBMED
abstract] |
| |
|
|
| |
82. |
Umeadi
C, Bentsi-Barnes K, Kandeel F, Al-Abdullah IH. Endogenous
Pancreatic Protease Activity and Methods for Impeding Their
Function. Transplantation Proceedings 2008. 40, 355-357
[PUBMED
abstract] |
| |
|
|
| |
83. |
Umeadi
C, Kandeel F, Al-Abdullah IH: Ulinastatin Is a Novel Protease Inhibitor and Neutral
Protease Activator. Transplant Proc. 2008 Mar;40(2):387-9.
[PUBMED]> |
| |
|
|
| |
84. |
Varona-Santos
JL, Pileggi A, Molano RD, Sanabria NY, Ijaz A, Atsushi M, Ichii H, Pastori RL, Inverardi L, Ricordi C, Fornoni A. c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets. Diabetologia. 2008 Dec;51(12):2271-80. Epub 2008 Oct 14.
[PUBMED
abstract] |
| |
|
|
| |
85. |
Vlad
G, D'Agati VD, Zhang QY, Liu Z, Ho EK, Mohanakumar T,
Hardy MA, Cortesini R, Suciu-Foca N. ILT3-FC Suppresses
T Cell Responses to Allogeneic Human Islet Transplants
in HU-NOD/SCID Mice. Diabetes 2008; Apr 16. [Epub ahead of print]
PMID: 18420485
[PUBMED
abstract] |
| |
|
|
| |
86. |
Xu
BY, Yu Y, Al-Abdullah IH, Kandeel F, Hering B, Wright Jr. JR: Long-Term
Survival and Function of Intraportal Porcine and Human Islet Xenografts
in Nondiabetic Nude Mice. Transplant Proc. 2008 Mar; 40(2):584-6. PMID:
18374135
[PUBMED] |
| |
|
|
| |
87. |
Yamamoto
T, Ricordi C, Mita A, Miki A, Sakuma Y, Molano RD, Fornoni A,
Pileggi A, Inverardi L, Ichii H: Beta-Cell Specific Cytoprotection
by Prolactin on Human Islets. Transplant Proc. 2008 Mar;40(2):382-3.
[PUBMED
abstract] |
| |
|
|
| |
2007 |
| |
|
|
| |
88. |
Ai
C, Todorov I, Slovak ML, Digiusto D, Forman SJ, Shih CC.
Human Marrow-Derived Mesodermal Progenitor Cells Generate
Insulin-Secreting Islet-Like Clusters In Vivo. Stem Cells
Dev 16, 757-770, 2007.
[PUBMED
abstract] |
| |
|
|
| |
89. |
Barbaro
B, Salehi P, Wang Y; Qi M, Gangemi A, Kuechle J, Hansen MA, Romagnoli T, Avila J,
Benedetti E, Mage R, Oberholzer J: Improved Human Pancreatic Islet Purification
With the Refined UIC-UB Density Gradient. Transplantation. 84(9):1200-1203, November
15, 2007.
[PUBMED
abstract] |
| |
|
|
| |
90. |
Barnett
BP, Arepally A, Karmarkar PV, Qian D, Gilson WD,
Walczak P, Howland V, Lawler L, Lauzon C, Stuber M,
Kraitchman DL, Bulte JW. Magnetic resonance-guided,
real-time targeted delivery and imaging of magnetocapsules
immunoprotecting pancreatic islet cells.
Nat Med. 2007 Sep;13(8):986-991. Epub 2007 Jul 29.[PUBMED
abstract] |
| |
|
|
| |
91. |
Bertuzzi
F, Ricordi C: Prediction of clinical outcome in islet allotransplantation. Diabetes
Care. 2007 Feb;30(2):410-7.
[PUBMED
abstract]
|
| |
|
|
| |
92. |
Chow
R, Michael D, Xiong W, Drain P: Pulsatile Insulin Secretion Imaged at the Single-Vesicle
Level in Human Pancreatic Beta Cells. Microscopy and Microanalysis 13 (Suppl 2): 322-323.
Aug 2007.
[ProQuest
abstract]
|
| |
|
|
| |
93. |
Clark
GO, Yochem RL, Axelman J, Sheets TP, Kaczorowski DJ, Shamblott MJ: Glucose
responsive insulin production from human embryonic germ (EG) cell derivatives.
Biochem Biophys Res Commun. 2007 May 11;356(3):587-93.
[PUBMED
abstract]
|
| |
|
|
| |
94. |
Davani
B, Ikonomou L, Raaka BM, Geras-Raaks E, Morton RA,
Marcus-Samuels B, Gershengorn MC. Human islet-derived
precursor cells are mesenchymal stromal cells that
differentiate and mature to hormone-expressing cells
in vivo. Stem Cells 2007. 25:3215. PMID: 17901402
Full Text - Stem Cells
|
| |
|
|
| |
95. |
De
Paula D, Bentley MV, Mahato RI: Effect of iNOS and NF-kappaB gene silencing on
beta-cell survival and function. J Drug Target. 2007 Jun;15(5):358-69.
[PUBMED
abstract]
|
| |
|
|
| |
96. |
Faradji
RN, Monroy K, Messinger S, Pileggi A, Froud T, Baidal
DA, Cure PE, Ricordi C, Luzi L, Alejandro R. Simple
measures to monitor beta-cell mass and assess islet
graft dysfunction. Am J Transplant. 2007 Feb;7(2):
303-8. Epub 2006 Dec 6.[PUBMED
abstract] |
| |
|
|
| |
97. |
Fisher
JS, Lakey JRT, Mirbolooki M, Robertson RP, Marsh CL.
Pancreas and Islet Transplantation. In: Comprehensive
Clinical Nephrology, 3rd Edition, p. 1131-1145. eds
Feehally, J, Floege J, Johnson RJ, 2007.
|
| |
|
|
| |
98. |
Ichii
H, Wang X, Messinger S, Alvarez A, Fraker C, Khan A,
Kuroda Y, Inverardi L, Goss JA, Alejandro R, Ricordi
C. Shipment of human islets for transplantation. Am
J Transplant. 2007 Apr;7(4):1010-20.
[PUBMED
abstract] |
| |
|
|
| |
99. |
Itakura
S, Asari S, Rawson J, Ito T, Todorov I, Liu CP, Sasaki N, Kandeel F, Mullen Y:
Mesenchymal stem cells facilitate the induction of mixed hematopoietic chimerism
and islet allograft tolerance without GVHD in the rat. Am J Transplant 2007 Feb;7
(2):336-46. PMID: 17283484
[PUBMED] |
| |
|
|
| |
100. |
Jia X,
Cheng K, Mahato RI. Coexpression of vascular endothelial
growth factor and interleukin-1 receptor antagonist for
improved human islet survival and function. Mol Pharm 2007.
Mar-Apr;4(2);199-207.
[PUBMED
abstract] |
| |
|
|
| |
101. |
Kayali
AG, Flores LE, Lopez AD, Kutlu B, Baetge E, Kitamura R,
Hao E, Beattie GM, Hayek A. Limited capacity of human
adult islets expanded in vitro to redifferentiate into
insulin-producing beta-cells. Diabetes. 2007 Mar;56(3):703-8.
[PUBMED
abstract] |
| |
|
|
| |
102. |
Ke
B, Oh E, Thurmond DC. Doc2beta is a novel Munc18c-
interacting partner and positive effector of syntaxin
4-mediated exocytosis. J Biol Chem. 2007 Jun 4.
[PUBMED
abstract] |
| |
|
|
| |
103. |
Luo
L, Badiavas E, Colvin G, Luo J, Maizel A: Allogeneic Bone Marrow Support Of
Human Pancreatic Islet's β-Cells. Biochem Biophys Res Commun. Volume 361,
Issue 4, 5 Oct 2007, Pages 859-864. PMID: 17686461
|
| |
|
|
| |
104. |
Michael
DJ, Xiong W, Geng X, Drain P, Chow RH: Human insulin vesicle dynamics during
pulsatile secretion. Diabetes. 2007 May;56(5):1277-88.
[PUBMED
abstract]
|
| |
| |
105. |
Mutskov
V, Raaka BM, Felsenfeld G, Gershengorn MC. The Human
Insulin Gene Displays Transcriptionally Active Epigenetic
Marks in Islet-derived Mesenchymal Precursor Cells in the
Absence of Insulin Expression. Stem Cells 2007 Sep 27;
[PUBMED
abstract] |
| |
|
|
| |
106. |
Omori
K, Shintaku J, Rawson J, Todorov I, Nair I, Al-Abdullah I, Higgins LS, Medicherla S,
Kandeel F, Mullen Y. P38 mitogen activated protein kinase inhibitor (p38IH) improved
the quality of cultured human islets. Xenotransplantation, Volume 14, Issue 5 (p 420).
|
| |
|
|
| |
107. |
Omori
K, Valiente L, Orr C, Rawson J, Ferreri K, Todorov I, Al-Abdullah I, Medicherla S,
Potter AA, Shreiner GF, Kandeel F, Mullen Y: Improvement of human islet cryopreservation
by a p38 MAPK inhibitor. Am J Transplant 7:1224-1232, May 2007
[PUBMED
abstract] |
| |
|
|
| |
108. |
Papas
KK, Colton CK, Nelson RA, Rozak PR, Avgoustiniatos ES,
Scott WE 3rd, Wildey GM, Pisania A, Weir GC, Hering BJ.
Human islet oxygen consumption rate and DNA measurements
predict diabetes reversal in nude mice. Am J Transplant.
2007 Mar;7(3):707-13. Epub 2007 Jan 4.
[PUBMED
abstract] |
| |
|
|
| |
109. |
Pissios
P, Ozcan U, Kokkotou E, Okada T, Liew CW, Liu S,
Peters JN, Dahlgren G, Karamchandani J, Kudva YC,
Kurpad AJ, Kennedy RT, Maratos-Flier E, Kulkarni RN.
Melanin Concentrating Hormone Is a Novel Regulator
of Islet Function and Growth. Diabetes 56(2):311-9,
2007.
[PUBMED
abstract] |
| |
|
|
| |
110. |
Qian
D, Kaddis J, Niland J. A matching algorithm for the
distribution of human pancreatic islets. Comput. Statist.
Data Anal. (2007), doi: 10.1013/j.csda.2007.02.030
[PUBMED
abstract] |
| |
|
|
| |
111. |
Rawson
J, Kandeel F, Mullen Y: Evaluation of three mouse models for in vivo quality
assessment of human islets: euglycemic NOD scid, multidoes- STZ diabetic NOD
scid and AKITA rag-/- mice. Xenotransplantation, Volume 14, Issue 5 (p 500).
|
| |
| |
112. |
Rickels MR,
Kamoun M, Kearns J, Markmann JF, Naji A. Evidence for
Allograft Rejection in an Islet Transplant Recipient
and Effect on {beta}-Cell Secretory Capacity. J Clin
Endocrinol Metab. 2007 Jul;92(7):2410-4. Epub 2007 May 8.
[PUBMED
abstract] |
| |
|
|
| |
113. |
Rickels MR,
Schutta MH, Mueller R, Kapoor S, Markmann JF, Naji A,
Teff KL. Glycemic thresholds for activation of counterregulatory
hormone and symptom responses in islet transplant recipients.
J Clin Endocrinol Metab. 2007 Mar;92(3):873-9. Epub 2006 Dec 27.
[PUBMED
abstract] |
| |
|
|
| |
114. |
Ritzel
RA, Meier JJ, Lin CY, Veldhuis JD, Butler PC. Human islet
amyloid polypeptide oligomers disrupt cell coupling, induce
apoptosis, and impair insulin secretion in isolated human islets.
Diabetes. 2007 Jan;56(1):65-71.
[PUBMED
abstract] |
| |
|
|
| |
115. |
Robertson
RP. Estimation of beta-cell mass by metabolic tests: necessary,
but how sufficient? Diabetes. 2007 Oct;56(10):2420-4.
Epub 2007 Jul 2.
Full Text -
Diabetes |
| |
|
|
| |
116. |
Robertson,
RP. Beta Cell Replacement: Pancreas and Islet Transplantation.
Type 1 Diabetes in Adults: Principles and Practice. p. 247-261.
Jabbour S, Stephens EA, Hirsch I, Goldstein BJ, Garg S, Riddle M,
eds. Informa Healthcare, plc. 2007.
|
| |
|
|
| |
117. |
Robertson
RP, Sutherland DER. Beta and alpha cell metabolic outcomes
after successful pancreas and islet transplantation at the
University of Minnesota. Clin Transpl 2007.
|
| |
|
|
| |
118. |
Sarkar
SA, Gunter J, Bouchard R, Reusch JE, Wiseman A, Gill
RG, Hutton JC, Pugazhenthi S. Dominant negative mutant
forms of the cAMP response element binding protein induce
apoptosis and decrease the anti-apoptotic action of
growth factors in human islets. Diabetologia. 2007
Aug;50(8):1649-59. Epub 2007 Jun 26.
[PUBMED
abstract] |
| |
|
|
| |
119. |
Sarkar
SA, Wong R, Hackl SI, Moua O, Gill RG, Wiseman A, Davidson HW, Hutton JC.
Induction of indoleamine 2,3-dioxygenase by interferon-gamma in human islets.
Diabetes 2007 Jan. 56(1):72-9.
[PUBMED
abstract]
|
| |
|
|
| |
120. |
Todorov
I, Nair I, Omori K, Ito T, Rawson J, Valiente L, Al-Abdullah I, Ferreri K,
Mullen Y, Kandeel F: Evaluation of cell composition and beta cell apoptosis
in isolated undissociated pancreatic islets by laser scanning cytometry.
Xenotransplantation, Volume 14, Issue 5 (p 499).
|
| |
| |
121. |
Tonooka
N, Oseid E, Zhou H, Harmon J, Robertson RP. Glutathione
peroxidase protein expression and activity in human islets
isolated for transplantation. Clin Transplant
21:767-772, 2007.
[PUBMED
abstract] |
| |
|
|
| |
122. |
Tracy
S, Drescher KM. Coxsackievirus infections and NOD mice:
relevant models of protection from, and induction of,
type 1 diabetes. Ann N Y Acad Sci. 2007 Apr;1103:143-51.
Epub 2007 Mar 21. Review.
[PUBMED
abstract] |
| |
|
|
| |
123. |
Vasavada
RC, Wang L, Fujinaka Y, Takane KK, Rosa TC, Mellado-Gil
JM, Friedman PA, Garcia-Ocana A. Protein Kinase C-{zeta}
Activation Markedly Enhances {beta}-Cell Proliferation:
An Essential Role in Growth Factor-Mediated {beta}-Cell
Mitogenesis. Diabetes. 2007 Aug 8; [Epub ahead of print]
[PUBMED
abstract] |
| |
|
|
| |
124. |
Wenzlau JM, Juhl K, Yu L, Moua O, Sarkar SA, Gottlieb P, Rewers M, Eisenbarth GS, Jensen J, Davidson HW, Hutton JC: The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17040-5.
[PUBMED
abstract] |
| |
|
|
| |
125. |
Yamamoto
T, Ricordi C, Messinger S, et al: Deterioration and Variability
of Highly Purified Collagenase Blends Used in Clinical Islet Isolation.
Transplantation 2007. Volume 84(8), 27 October 2007, pp 997-1002.
[PUBMED
abstract] |
| |
|
|
| |
126. |
Yatoh S,
Dodge R, Akashi T, Omer A, Sharma A, Weir GC, Bonner-Weir
S. Differentiation of affinity-purified human pancreatic
duct cells to beta-cells. Diabetes. 2007 Jul;56(7):1802-9. Epub 2007 May 1.
[PUBMED
abstract] |
| |
|
|
| |
2006 |
| |
|
|
| |
127. |
Barbé-Tuana
FM, Klein D, Ichii H, Berman DM, Coffey L, Kenyon
NS, Ricordi C, Pastori RL: CD40–CD40 Ligand
Interaction Activates Proinflammatory Pathways in
Pancreatic Islets. Diabetes 55:2437-2445,
2006 [PUBMED
abstract] |
| |
|
|
| |
128. |
Cabrera
O, Berman DM, Kenyon NS, Ricordi C, Berggren PO,
Caicedo A: The unique cytoarchitecture of human
pancreatic islets has implications for islet cell
function. Proc.Natl.Acad.Sci.U.S.A 103:2334-2339,
2006 [PUBMED
abstract] |
| |
|
|
| |
129. |
Cozar-Castellano
I, Fiaschi-Taesch N, Bigatel TA, Takane KK, Garcia-Ocana A,
Vasavada R, Stewart AF. Molecular control of cell cycle
progression in the pancreatic beta-cell. Endocr Rev. 2006
Jun;27(4):356-70. Epub 2006 Apr 25. Review.
[PUBMED
abstract] |
| |
|
|
| |
130. |
Evgenov
NV, Medarova Z, Dai G, Bonner-Weir S, Moore A. In vivo
imaging of islet transplantation. Nat Med. 2006
Jan;12(1):144-8. Epub 2005 Dec 25.
[PUBMED
abstract] |
| |
|
|
| |
131. |
Evgenov
NV, Medarova Z, Pratt J, Pantazopoulos P, Leyting
S, Bonner-Weir S, Moore A: In Vivo Imaging of Immune
Rejection in Transplanted Pancreatic Islets. Diabetes
55: 2419-2428, 2006 [PUBMED
abstract] |
| |
|
|
| |
132. |
Gianani
R, Putnam A, Still T, Yu L, Miao D, Gill RG, Beilke J, Supon P,
Valentine A, Iveson A, Dunn S, Eisenbarth GS, Hutton J, Gottlieb
P, Wiseman A: Initial results of screening of non - diabetic organ
donors for expression of islet autoantibodies. J.Clin.Endocrinol.Metab
2006 May 91 (5):1855-61 Epub 2006 Feb 14. [PUBMED
abstract] |
| |
|
|
| |
133. |
Hao
E, Tyrberg B, Itkin-Ansari P, Lakey JR, Geron I,
Monosov EZ, Barcova M, Mercola M, Levine F. Beta-cell
differentiation from nonendocrine epithelial cells
of the adult human pancreas. Nat Med. 2006 Mar;12(3):310-6.
Epub 2006 Feb 19.
[PUBMED
abstract] |
| |
|
|
| |
134. |
Ichii H,
Wang X, Messinger S, Alvarez A, Fraker C,
Khan A, Kuroda Y, Inverardi L, Goss JA,
Alejandro R, Ricordi C. Improved human islet
isolation using nicotinamide. Am J Transplant.
2006 Sep;6(9):2060-8. Epub 2006 Jul 6.
[PUBMED
abstract] |
| |
|
|
| |
135. |
Ihm
SH, Matsumoto I, Sawada T, Nakano M, Zhang HJ, Ansite
JD, Sutherland DE, Hering BJ. Effect of donor age
on function of isolated human islets. Diabetes 2006
May;55(5):1361-8. [PUBMED
abstract] |
| |
|
|
| |
136. |
Kaido
T, Yebra M, Cirulli V, Rhodes C, Diaferia G, Montgomery
AM. Impact of defined matrix interactions on insulin
production by cultured human beta-cells: effect
on insulin content, secretion, and gene transcription.
Diabetes 2006 Oct;55(10):2723-9. [PUBMED
abstract] |
| |
|
|
| |
137. |
Kang
G, Chepurney OG, Malester B, Rindler MJ, Relumann
H, Bos JL, Schwede F, Coetzee WA, Holz GG: cAMP
Sensor Epac As A Determinant of ATP-Sensitive Potassium
Channel Activity in Human Pancreatic Beta Cells
And Rat INS-1 Cells. J Physiol 573.3: 595-609, 2006
[PUBMED
abstract] |
| |
|
|
| |
138. |
Lu
Y, Dang H, Middleton B, Zhang Z, Washburn L, Stout
DB, Campbell-Thompson M, Atkinson MA, Phelps M,
Gambhir SS, Tian J, Kaufman DL: Noninvasive imaging
of islet grafts using positron-emission tomography.
PNAS 103: 11294-11299, 2006 [PUBMED
abstract] |
| |
|
|
| |
139. |
Lu
Y, Dang H, Middleton B, Campbell-Thompson M, Atkinson
MA, Gambhir SS, Tian J, Kaufman DL. Long-term monitoring
of transplanted islets using positron emission tomography.
Mol Ther. 2006 Dec;14(6):851-6. Epub 2006 Sep 18.
[PUBMED
abstract] |
| |
|
|
| |
140. |
Medarova
Z, Evgenov NV, Dai G, Bonner-Weir S, Moore A. In vivo
multimodal imaging of transplanted pancreatic islets.
Nat Protoc. 2006;1(1):429-35.
[PUBMED
abstract] |
| |
|
|
| |
141. |
Meier JJ,
Kayed R, Lin CY, Gurlo T, Haataja L, Jayasinghe S,
Langen R, Glabe CG, Butler PC. Inhibition of human IAPP
fibril formation does not prevent beta-cell death: evidence
for distinct actions of oligomers and fibrils of human IAPP.
Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1317-24.
Epub 2006 Jul 18.
[PUBMED
abstract] |
| |
|
|
| |
142. |
Meier JJ,
Ritzel RA, Maedler K, Gurlo T, Butler PC. Increased
vulnerability of newly forming beta cells to cytokine-induced
cell death. Diabetologia. 2006 Jan;49(1):83-9. Epub 2005 Dec 2.
[PUBMED
abstract] |
| |
|
|
| |
143. |
Metz
TO, Jacobs JM, Gritsenko MA, Fontes G, Qian WJ, Camp
DG 2nd, Poitout V, Smith RD. Characterization of the
human pancreatic islet proteome by two-dimensional
LC/MS/MS. J Proteome Res. 2006 Dec;5(12):3345-54.
[PUBMED
abstract] |
| |
|
|
| |
144. |
Michael
DJ, Ritzel RA, Haataja L, Chow RH: Pancreatic {beta}-Cells Secrete Insulin in
Fast- and Slow-Release Forms. Diabetes 55: 600-607, 2006
[PUBMED] |
| |
| |
145. |
Mohanakumar
T, Narayanan K, Desai N, Ramachandran S, Shenoy
S, Jendrisak M, Susskind BM, Olack B, Benshoff N,
Phelan DL, Brennan DC, Fernandez LA, Odorico JS,
Polonsky KS: A significant role for histocompatibility
in human islet transplantation. Transplantation
Jul 27;82(2):180-7, 2006 [PUBMED
abstract] |
| |
|
|
| |
146. |
Narang
AS, Sabek O, Gaber AO, Mahato RI: Co-expression
of vascular endothelial growth factor and interleukin-1
receptor antagonist improves human islet survival
and function. Pharm Res. 2006 Sep;23(9):1970-82.
Epub 2006 Aug 12. [PUBMED
abstract] |
| |
|
|
| |
147. |
Ouziel-Yahalom L,
Zalzman M, Anker-Kitai L, Knoller S, Bar
Y, Glandt M, Herold K, Efrat S. Expansion
and redifferentiation of adult human pancreatic
islet cells. Biochem Biophys Res Commun. 2006
Mar 10;341(2):291-8. Epub 2006 Jan 19.
[PUBMED
abstract] |
| |
|
|
| |
148. |
Poggioli
R, Faradji RN, Ponte G, Betancourt A, Messinger
S, Baidal DA, Froud T, Ricordi C, Alejandro R: Quality
of life after islet transplantation. Am.J.Transplant
6:371-378, 2006 [PUBMED
abstract] |
| |
|
|
| |
149. |
Rickels
MR, Naji A, Teff KL: Insulin Sensitivity, Glucose
Effectiveness, and Free Fatty Acid Dynamics after
Human Islet Transplantation for Type 1 Diabetes.
J. Clin. Endocrinol. Metab. 91: 2138-2144, 2006
[PUBMED
abstract] |
| |
|
|
| |
150. |
Ritzel
RA, Veldhuis JD, Butler PC. The mass, but not the frequency,
of insulin secretory bursts in isolated human islets is
entrained by oscillatory glucose exposure. Am J Physiol
Endocrinol Metab. 2006 Apr;290(4):E750-6. Epub 2005 Nov 8.
[PUBMED
abstract] |
| |
|
|
| |
151. |
Robertson
RP, Harmon JS. Diabetes, glucose toxicity, and
oxidative stress: a case of double jeopardy for
the pancreatic beta cell. Free Rad Biol Med 2006
Jul 15; 41(2):177-84.
[PUBMED
abstract] |
| |
|
|
| |
152. |
Robertson
RP. Replacing Beta Cells in Diabetes. In Commentaries on
Perspectives in Diabetes, Vol 1 (1988-1993), p. 212-217.
Robertson RP, ed. American Diabetes Association. 2006.
|
| |
|
|
| |
153. |
Robertson,
RP. What is successful islet transplantation
in 2006? European Endocrine Disease 2006 Issue 2.
|
| |
|
|
| |
154. |
Robertson
RP, Davis C, Larsen J, Stratta R, Sutherland DE;
American Diabetes Association Position Statement.
Pancreas and Islet Transplantation in Type 1
Diabetes Diabetes Care 29:35, 2006.
Full Text - Diabetes
|
| |
|
|
| |
155. |
Sabek OM,
Marshall DR, Penmetsa R, Scarborough O, Gaber AO.
Examination of gene expression profile of functional
human pancreatic islets after 2-week culture.
Transplant Proc. 2006 Dec;38(10):3678-9.
[PUBMED
abstract] |
| |
|
|
| |
156. |
Scacheri
PC, Davis S, Odom DT, Crawford GE, Perkins S, Halawi
MJ, Agarwal SK, Marx SJ, Spiegel AM, Meltzer PS,
Collins FS. Genome-wide analysis of menin binding
provides insights into MEN1 tumorigenesis. PLoS
Genet 2006 Apr;2(4):e51. Epub 2006 Apr 7 [PUBMED
abstract] |
| |
|
|
| |
157. |
Shanmugam N,
Todorov IT, Nair I, Omori K, Reddy MA, Natarajan R.
Increased expression of cyclooxygenase-2 in human
pancreatic islets treated with high glucose or ligands
of the advanced glycation endproduct-specific receptor
(AGER), and in islets from diabetic mice. Diabetologia.
2006 Jan;49(1):100-7. Epub 2005 Dec 10. [PUBMED
abstract] |
| |
|
|
| |
158. |
Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, Secchi A, Brendel MD, Berney T, Brennan DC, Cagliero E, Alejandro R, Ryan EA, DiMercurio B, Morel P, Polonsky KS, Reems JA, Bretzel RG, Bertuzzi F, Froud T, Kandaswamy R, Sutherland DE, Eisenbarth G, Segal M, Preiksaitis J, Korbutt GS, Barton FB, Viviano L, Seyfert-Margolis V, Bluestone J, Lakey JR. International Multicenter Trial of Islet Transplantation in Type 1 Diabetes Using the Edmonton Protocol. N Engl J Med 355(13):1318-30. 2006.
[PUBMED
abstract] |
| |
|
|
| |
159. |
Steer
SA, Scarim AL, Chambers KT, Corbett JA. Interleukin-1
stimulates beta-cell necrosis and release of the
immunological adjuvant HMGB1. PLoS Med 2006 Feb;3(2):e17.
Epub 2005 Dec 20. [PUBMED
abstract] |
| |
|
|
| |
160. |
Todorov
I, Omori K, Pascual M, Rawson J, Nair I, Valiente
L, Vuong T, Matsuda T, Orr C, Ferreri K, Smith CV,
Kandeel F, Mullen Y. Generation of human islets
through expansion and differentiation of non-islet
pancreatic cells discarded (pancreatic discard)
after islet isolation. Pancreas 2006 Mar;32(2):130-8.
[PUBMED
abstract] |
| |
|
|
| |
161. |
Yang
J, Wong RK, Park M, Wu J, Cook JR, York DA, Deng
S, Markmann J, Naji A, Wolf BA, Gao Z: Leucine regulation
of glucokinase and ATP synthase sensitizes glucose-induced
insulin secretion in pancreatic beta-cells. Diabetes
55:193-201, 2006 [PUBMED
abstract] |
| |
|
|
| |
162. |
Zhang
G, Matsumoto S, Newman H, Strong DM, Robertson RP,
Reems JA. Improve islet yields and quality when
clinical grade pancreata are preserved by the two-layer
method. Cell Tissue Bank 2006;7(3):195-201. [PUBMED
abstract] |
| |
|
|
|
2005 |
| |
|
|
| |
163. |
Albisser
AM, Alejandro R, Meneghini LF, Ricordi C: How good is your glucose
control? Diabetes Technol.Ther. 7:863-875, 2005
[PUBMED
abstract] |
| |
|
|
| |
164. |
Albisser
AM, Baidal D, Alejandro R, Ricordi C: Home blood glucose prediction:
clinical feasibility and validation in islet cell transplantation candidates.
Diabetologia 2005 Jul;48(7):1273-9. Epub 2005 Jun 3.
[PUBMED
abstract] |
| |
|
|
| |
165. |
Bharat
A, Benshoff N, Olack B, Ramachandran S, Desai NM,
Mohanakumar T: Novel in vivo murine model to study
islet potency: engraftment and function. Transplantation
79:1627-1630, 2005 [PUBMED
abstract] |
| |
|
|
| |
166. |
Brissova
M, Fowler MJ, Nicholson WE, Chu A, Hirshberg B,
Harlan DM, Powers AC: Assessment of Human Pancreatic
Islet Architecture and Composition by Laser Scanning
Confocal Microscopy. J. Histochem. Cytochem 53:
1087-1097, 2005 [PUBMED
abstract] |
| |
|
|
| |
167. |
Faradji
RN, Monroy K, Cure P, Froud T, Baidal D, Pileggi
A, Messinger S, Ricordi C, Alejandro R: C-peptide
and glucose values in the peritransplant period
after intraportal islet infusions in type 1 diabetes.
Transplant Proc. 37:3433-3434, 2005 [PUBMED
abstract] |
| |
|
|
| |
168. |
Fowler
M, Virostko J, Chen Z, Poffenberger G, Radhika A,
Brissova M, Shiota M, Nicholson WE, Shi Y, Hirshberg
B, Harlan DM, Jansen ED, Powers AC. Assessment of
pancreatic islet mass after islet transplantation
using in vivo bioluminescence imaging. Transplantation
2005 Apr 15;79(7):768-76 [PUBMED
Abstract] |
| |
|
|
| |
169.
|
Fraga
DW, Gaber AO, Kotb M: Long-term culture and maintenance
of human islets of Langerhans in memphis serum-free
media. Methods Mol.Med. 107:303-311, 2005
[PUBMED
Abstract] |
| |
|
|
| |
170. |
Froud
T, Ricordi C, Baidal DA, Hafiz MM, Ponte G, Cure
P, Pileggi A, Poggioli R, Ichii H, Khan A, Ferreira
JV, Pugliese A, Esquenazi VV, Kenyon NS, Alejandro
R: Islet transplantation in type 1 diabetes mellitus
using cultured islets and steroid-free immunosuppression:
Miami experience. Am.J.Transplant 5:2037-2046,
2005 [PUBMED
abstract] |
| |
|
|
| |
171. |
Fukui
K, Yang Q, Cao Y, Takahashi N, Hatakeyama H, Wang
H, Wada J, Zhang Y, Marselli L, Nammo T, Yoneda
K, Onishi M, Higashiyama S, Matsuzawa Y, Gonzalez
FJ, Weir GC, Kasai H, Shimomura I, Miyagawa J, Wollheim
CB, Yamagata K: The HNF-1 target collectrin controls
insulin exocytosis by SNARE complex formation. Cell
Metab 2:373-384, 2005 [PUBMED
abstract] |
| |
|
|
| |
172.
|
Geiger
MC, Ferreira JV, Hafiz MM, Froud T, Baidal DA, Meneghini
LF, Ricordi C, Alejandro R: Evaluation of metabolic
control using a continuous subcutaneous glucose
monitoring system in patients with type 1 diabetes
mellitus who achieved insulin independence after
islet cell transplantation. Cell Transplant
14:77-84, 2005 [PUBMED
Abstract] |
| |
|
|
| |
173. |
Gunton
JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng
YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez
FJ, Kahn CR: Loss of ARNT/HIF1beta mediates altered
gene expression and pancreatic-islet dysfunction
in human type 2 diabetes. Cell 122:337-349,
2005 [PUBMED
abstract] |
| |
|
|
| |
174. |
Hafiz
MM, Faradji RN, Froud T, Pileggi A, Baidal DA, Cure
P, Ponte G, Poggioli R, Cornejo A, Messinger S,
Ricordi C, Alejandro R: Immunosuppression and procedure-related
complications in 26 patients with type 1 diabetes
mellitus receiving allogeneic islet cell transplantation.
Transplantation 80:1718-1728, 2005 [PUBMED
abstract] |
| |
|
|
| |
175. |
Han
D, Leith J, Alejandro R, Bolton W, Ricordi C, Kenyon
NS: Peripheral blood cytotoxic lymphocyte gene transcript
levels differ in patients with long-term type 1
diabetes compared to normal controls. Cell Transplant
14:403-409, 2005 [PUBMED
abstract] |
| |
|
|
| |
176.
|
Hering
BJ: Achieving and maintaining insulin independence
in human islet transplant recipients. Transplantation
79:1296-1297, 2005 [PUBMED
Abstract] |
| |
|
|
| |
177.
|
Hering
BJ, Kandaswamy R, Ansite JD, Eckman PM, Nakano M,
Sawada T, Matsumoto I, Ihm SH, Zhang HJ, Parkey
J, Hunter DW, Sutherland DE: Single-donor, marginal-dose
islet transplantation in patients with type 1 diabetes.
JAMA 293:830-835, 2005 [PUBMED
Abstract] |
| |
|
|
| |
178. |
Ichii H, Inverardi L, Pileggi A, Molano RD, Cabrera
O, Caicedo A, Messinger S, Kuroda Y, Berggren PO,
Ricordi C: A novel method for the assessment of
cellular composition and beta-cell viability in
human islet preparations. Am.J.Transplant
5:1635-1645, 2005 [PUBMED
abstract] |
| |
|
|
| |
179.
|
Ichii
H, Pileggi A, Molano RD, Baidal DA, Khan A, Kuroda
Y, Inverardi L, Goss JA, Alejandro R, Ricordi C:
Rescue purification maximizes the use of human islet
preparations for transplantation. Am.J.Transplant
5:21-30, 2005 [PUBMED
Abstract] |
| |
|
|
| |
180. |
Ichii
H, Pileggi A, Wang X, Khan A, Kuroda Y, Inverardi L, Alejandro R, Ricordi C:
Pre-transplant assessment of cultured islets prior to clinical islet transplantation.
American Journal of Transplantation. 5 (S11):790;2005
|
| |
| |
181. |
Jacobson
PA, Green KG, Hering BJ: Mycophenolate mofetil in
islet cell transplant: variable pharmacokinetics
but good correlation between total and unbound concentrations.
J.Clin.Pharmacol. 45:901-909, 2005 [PUBMED
abstract] |
| |
|
|
| |
182. |
Klein D,
Barbe-Tuana F, Pugliese A, Ichii H, Garza D, Gonzalez M,
Molano RD, Ricordi C, Pastori RL. A functional CD40 receptor
is expressed in pancreatic beta cells. Diabetologia. 2005
Feb;48(2):268-76. Epub 2005 Feb 3.
[PUBMED
abstract] |
| |
|
|
| |
183. |
Lechner
A, Nolan AL, Blacken RA, Habener JF. Redifferentiation
of insulin-secreting cells after in vitro expansion
of adult human pancreatic islet tissue. Biochem
Biophys Res Commun 2005 Feb 11;327(2):581-8 [PUBMED
Abstract] |
| |
|
|
| |
184. |
Lin
CY, Gurlo T, Haataja L, Hsueh WA, Butler PC.: Activation of peroxisome proliferator-activated
receptors-gamma (PPAR-gamma) by rosiglitazone protects human islet cells against human-islet
amyloid polypeptide toxicity by a PI3 kinase-dependent pathway. J Clin Endocrinol Metab. 2005
Dec;90(12):6678-86. Epub 2005 Oct 4.
[PUBMED
abstract] |
| |
|
|
| |
185.
|
Marshall
D, Sabek O, Fraga D, Kotb M, Gaber AO: Examination
of the molecular signature associated with islet
dysfunction. Transplant Proc. 37:1311-1312,
2005 [PUBMED
Abstract] |
| |
|
|
| |
186. |
Matsuda
T, Omori K, Vuong T, Pascual M, Valiente L, Ferreri
K, Todorov I, Kuroda Y, Smith CV, Kandeel F, Mullen
Y. Inhibition of p38 pathway suppresses human islet
production of pro-inflammatory cytokines and improves
islet graft function. Am J Transplant 2005 Mar;5(3):484-93
[PUBMED
Abstract] |
| |
|
|
| |
187. |
Matsuda
T, Ferreri K, Todorov I, Duroda Y, Smith CV, Kandeel F, Mullen: Silymarin
Protects Pancreatic �-Cells against Cytokine-Mediated Toxicity: Implication
of c-Jun NH2-Terminal Kinase and Janus Kinase/Signal Transducer and Activator
of Transcription Pathways. Endocrinology 146: 175-185 Jan 2005
[PUBMED] |
| |
| |
188.
|
Mendoza
V, Klein D, Ichii H, Ribeiro MM, Ricordi C, Hankeln
T, Burmester T, Pastori RL: Protection of islets
in culture by delivery of oxygen binding neuroglobin
via protein transduction. Transplant Proc.
37:237-240, 2005 [PUBMED
Abstract] |
| |
|
|
| |
189. |
Narang
AS, Thoma L, Miller DD, Mahato RI: Cationic lipids with increased DNA binding
affinity for nonviral gene transfer in dividing and nondividing cells. Bioconjug
Chem. 2005 Jan-Feb;16(1):156-68.
[PUBMED] |
| |
| |
190. |
Nath
DS, Hering BJ: Islet cells replacement therapy. Clin.Lab Med.
2005 Sep; 25(3):541-56
[PUBMED
abstract] |
| |
|
|
| |
191. |
Omori K, Valiente L,
Orr C, Rawson J, Ferreri K, Todorov I, Medicherla S,
Protter AA, Schreiner GF, Riggs AD, Kandeel F, Mullen
Y. Inhibition of p38 mitogen-activated protein kinase
protects human islets from cryoinjury and improves the
yield, viability, and quality of frozen-thawed islets.
Transplant Proc. 2005 Oct;37(8):3422-3.[PUBMED
abstract] |
| |
|
|
| |
192. |
Papas
KK, Avgoustiniatos ES, Tempelman LA, Weir GC, Colton
CK, Pisania A, Rappel MJ, Friberg AS, Bauer AC,
Hering BJ: High-density culture of human islets
on top of silicone rubber membranes. Transplant
Proc. 37:3412-3414, 2005 [PUBMED
abstract] |
| |
|
|
| |
193. |
Papas
KK, Hering BJ, Gunther L, Rappel MJ, Colton CK,
Avgoustiniatos ES: Pancreas oxygenation is limited
during preservation with the two-layer method. Transplant
Proc. 37:3501-3504, 2005 [PUBMED
abstract] |
| |
|
|
| |
194.
|
Poggioli
R, Froud T, Baidal DA, Ferreira JV, Hafiz MM, Ricordi
C, Gleich GJ, Alejandro R: Hypereosinophilia in
an islet transplant recipient. Transplantation
79:853-854, 2005 [PUBMED
Abstract] |
| |
|
|
| |
195.
|
Rickels
MR, Schutta MH, Markmann JF, Barker CF, Naji A,
Teff KL: {beta}-Cell Function Following Human Islet
Transplantation for Type 1 Diabetes. Diabetes
54:100-106, 2005 [PUBMED
Abstract] |
| |
|
|
| |
196. |
Rickels
MR, Schutta MH, Mueller R, Markmann JF, Barker CF,
Naji A, Teff KL: Islet Cell Hormonal Responses to
Hypoglycemia After Human Islet Transplantation for
Type 1 Diabetes. Diabetes 54: 3205-3211, 2005 [PUBMED
abstract] |
| |
|
|
| |
197.
|
Ricordi
C, Inverardi L, Kenyon NS, Goss J, Bertuzzi F, Alejandro
R: Requirements for success in clinical islet transplantation.
Transplantation 79:1298-1300, 2005 [PUBMED
Abstract] |
| |
|
|
| |
198.
|
Robertson
RP, Tanaka Y, Takahashi H, Tran POT, Harmon JS. Prevention
of oxidative stress by adenoviral overexpression of glutathione-related
enzymes in pancreatic islets. Ann New York Acad Sci
2005 Jun;1043:513-20.
[PUBMED
Abstract] |
| |
|
|
| |
199. |
Sabek
OM, Fraga DW, Minoru O, McClaren JL, Gaber AO: Assessment
of human islet viability using various mouse models.
Transplant Proc. 37:3415-3416, 2005 [PUBMED
abstract] |
| |
|
|
| |
200. |
Sabek
OM, Marshall DR, Minoru O, Fraga DW, Gaber AO: OP-142
gene expression profile of nonfunctional human pancreatic
islets: predictors of transplant failure? Transplant
Proc. 37:3441-3443, 2005 [PUBMED
abstract] |
| |
|
|
| |
201. |
Sweet
IR, Gilbert M, Jensen R, Sabek O, Fraga DW, Gaber
AO, Reems J: Glucose stimulation of cytochrome C
reduction and oxygen consumption as assessment of
human islet quality. Transplantation 80:1003-1011,
2005 [PUBMED
abstract] |
| |
|
|
| |
202. |
Todorov I,
Nair I, Ferreri K, Rawson J, Kuroda A, Pascual
M, Omori K, Valiente L, Orr C, Al-Abdullah I, Riggs A,
Kandeel F, Mullen Y. Multipotent progenitor cells
isolated from adult human pancreatic tissue.
Transplant Proc. 2005 Oct;37(8):3420-1.
[PUBMED
abstract] |
| |
|
|
| |
203. |
Wang
W, Upshaw L, Strong DM, Robertson RP, Reems J: Increased
oxygen consumption rates in response to high glucose
detected by a novel oxygen biosensor system in non-human
primate and human islets. J.Endocrinol.
185:445-455, 2005 [PUBMED
abstract] |
| |
|
|
| |
204. |
Witkowski
P, Liu Z, Guo Q, Poumian-Ruiz E, Cernea S, Herold
K, Hardy MA: Two-layer method in short-term pancreas
preservation for successful islet isolation. Transplant
Proc. 37:3398-3401, 2005 [PUBMED
abstract] |
| |
|
|
| |
205. |
Yang
Z, Chen M, Ellett JD, Carter JD, Brayman KL, Nadler
JL. Inflammatory blockade improves human pancreatic
islet function and viability. Am J Transplant 2005
Mar;5(3):475-83. [PUBMED
abstract] |
| |
|
|
| |
206. |
Zheng
Q, Dai H, Merritt ME, Malloy C, Pan CY, Li W-H: A new class of macrocyclic
lanthanide complexes for cell labeling and magnetic resonance imaging
applications. J. Am. Chem. Soc., 2005, 127 (46), 16178-16188 27 October 2005
|
| |
|
2004 |
| |
|
|
| |
207.
|
Abdelli
S, Ansite J, Roduit R, Borsello T, Matsumoto I,
Sawada T, Allaman-Pillet N, Henry H, Beckmann JS,
Hering BJ, Bonny C: Intracellular stress signaling
pathways activated during human islet preparation
and following acute cytokine exposure. Diabetes
53:2815-2823, 2004 [PUBMED
Abstract] |
| |
|
|
| |
208. |
Brissova
M, Fowler M, Wiebe P, Shostak A, Shiota M, Radhika
A, Lin PC, Gannon M, Powers AC. Intraislet endothelial
cells contribute to revascularization of transplanted
pancreatic islets. Diabetes 2004 May;53(5):1318-25
[PUBMED
Abstract] |
| |
|
|
| |
209.
|
Cheng
K, Fraga D, Zhang C, Kotb M, Gaber AO, Guntaka RV,
Mahato RI: Adenovirus-based vascular endothelial
growth factor gene delivery to human pancreatic
islets. Gene Ther. 11:1105-1116, 2004 [PUBMED
abstract] |
| |
|
|
| |
210.
|
Cure
P, Pileggi A, Froud T, Norris PM, Baidal DA, Cornejo
A, Hafiz MM, Ponte G, Poggioli R, Yu J, Saab A,
Selvaggi G, Ricordi C, Alejandro R: Alterations
of the female reproductive system in recipients
of islet grafts. Transplantation 78:1576-1581,
2004 [PUBMED
Abstract] |
| |
|
|
| |
211. |
Fenjves
ES, Ochoa MS, Gay-Rabinstein C, Ricordi C, Curran MA: Retrovirally transferred
genes inhibit apoptosis in an insulin-secreting cell line: implications for islet
transplantation. Cell Transplant 2004; 13(5):489-96.
[PUBMED] |
| |
| |
212.
|
Gaber AO, Fraga D, Kotb M, Lo A, Sabek O, Latif
K: Human islet graft function in NOD-SCID mice predicts
clinical response in islet transplant recipients.
Transplant Proc. 36:1108-1110, 2004 [PUBMED
abstract] |
| |
|
|
| |
213.
|
Hafiz
MM, Poggioli R, Caulfield A, Messinger S, Geiger
MC, Baidal DA, Froud T, Ferreira JV, Tzakis AG,
Ricordi C, Alejandro R: Cytomegalovirus prevalence
and transmission after islet allograft transplant
in patients with type 1 diabetes mellitus. Am.J.Transplant
4:1697-1702, 2004 [PUBMED
Abstract] |
| |
|
|
| |
214.
|
Han
D, Xu X, Baidal D, Leith J, Ricordi C, Alejandro
R, Kenyon NS: Assessment of cytotoxic lymphocyte
gene expression in the peripheral blood of human
islet allograft recipients: elevation precedes clinical
evidence of rejection. Diabetes 53:2281-2290,
2004 [PUBMED
abstract] |
| |
|
|
| |
215. |
Holz
GG. Epac: A new cAMP-binding protein in support
of glucagon-like peptide-1 receptor-mediated signal
transduction in the pancreatic beta-cell. Diabetes
2004 Jan;53(1):5-13 [PUBMED
abstract] |
| |
|
|
| |
216. |
Hope
KM, Tran POT, Zhou H, Oseid E, LeRoy E, Robertson RP.
Regulation of Alpha Cell Function by the Beta Cell in
Isolated Human and Rat Islets Deprived of Glucose: the
"Switch-off" Hypothesis. Diabetes 53:1488-1495, 2004.
PMID: 15161753
|
| |
|
|
| |
217. |
Kaido
T, Yebra M, Cirulli V, Montgomery AM: Regulation of human beta-cell adhesion,
motility, and insulin secretion by collagen IV and its receptor alpha1beta1.
J Biol Chem 2004 Dec 17;279(51):53762-9. Epub 2004 Oct 12
6. [PUBMED
abstract] |
| |
|
|
| |
218. |
Kaido
T, Perez B, Yebra M, Hill J, Cirulli V, Hayek A, Montgomery AM: Alphav-integrin
utilization in human beta-cell adhesion, spreading, and motility. J Biol Chem
2004 Apr 23;279(17):17731-7. Epub 2004 Feb 6.
[PUBMED
abstract] |
| |
|
|
| |
219.
|
Klein
D, Ribeiro MM, Mendoza V, Jayaraman S, Kenyon NS,
Pileggi A, Molano RD, Inverardi L, Ricordi C, Pastori
RL: Delivery of Bcl-XL or its BH4 domain by protein
transduction inhibits apoptosis in human islets.
Biochem.Biophys.Res.Commun. 323:473-478,
2004 [PUBMED
Abstract] |
| |
|
|
| |
220.
|
Maffei
A, Liu Z, Witkowski P, Moschella F, Del Pozzo G,
Liu E, Herold K, Winchester RJ, Hardy MA, Harris
PE: Identification of Tissue Restricted Transcripts
in Human Islets. Endocrinology 2004 [PUBMED
abstract] |
| |
|
|
| |
221.
|
Matsumoto
I, Sawada T, Nakano M, Sakai T, Liu B, Ansite JD,
Zhang HJ, Kandaswamy R, Sutherland DE, Hering BJ:
Improvement in Islet Yield from Obese Donors for
Human Islet Transplants. Transplantation
78:880-885, 2004 [PUBMED
Abstract] |
| |
|
|
| |
222.
|
Matsumoto
S, Tanaka K, Strong DM, Reems JA: Efficacy of Human
Islet Isolation From the Tail Section of the Pancreas
for the Possibility of Living Donor Islet Transplantation.
Transplantation 78:839-843, 2004 [PUBMED
Abstract] |
| |
|
|
| |
223.
|
Narang
AS, Cheng K, Henry J, Zhang C, Sabek O, Fraga D,
Kotb M, Gaber AO, Mahato RI: Vascular endothelial
growth factor gene delivery for revascularization
in transplanted human islets. Pharm.Res.
21:15-25, 2004 [PUBMED
abstract] |
| |
|
|
| |
224.
|
Pileggi
A, Fenjves ES, Klein D, Ricordi C, Pastori RL: Protecting
pancreatic beta-cells. IUBMB.Life 56:387-394,
2004 [PUBMED
Abstract] |
| |
|
|
| |
225. |
Ritzel
RA, Hansen JB, Veldhuis JD, Butler PC. Induction
of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel
opener preserves beta-cell insulin stores and insulin
secretion in human islets cultured at high (11 mM)
glucose. J Clin Endocrinol Metab 2004 Feb;89(2):795-805
[PUBMED
Abstract] |
| |
|
|
| |
226.
|
Rush
BT, Fraga DW, Kotb MY, Sabek OM, Lo A, Gaber LW,
Halim AB, Gaber AO: Preservation of human pancreatic
islet in vivo function after 6-month culture in
serum-free media. Transplantation 77:1147-1154,
2004 [PUBMED
abstract] |
| |
| |
227.
|
Sweet
IR, Cook DL, DeJulio E, Wallen AR, Khalil G, Callis
J, Reems J: Regulation of ATP/ADP in Pancreatic
Islets. Diabetes 53:401-409, 2004 [PUBMED
abstract] |
| |
|
|
| |
228. |
Virostko
J, Fowler M, Chen Z, Powers AC, Jansen ED: Factors influencing quantification of
in vivo bioluminescence imaging: application to assessment of pancreatic islet
transplants. Molecular Imaging 4:1-10, 2004
[PUBMED
abstract] |
| |
|
|
| |
229.
|
Wiseman
AC, Gill RG: Current status of clinical
islet transplantation: advances and obstacles. Curr
Opin Endocrinol Diabetes. 11:98-103, 2004 [No
Abstract Available] |
| |
| |
230.
|
Zhang
G, Matsumoto S, Hyon SH, Qualley SA, Upshaw L, Strong
DM, Reems JA: Polyphenol, an Extract of Green Tea,
Increases Culture Recovery Rates of Isolated Islets
From Nonhuman Primate Pancreata and Marginal Grade
Human Pancreata. Cell Transplantation 13:145-152
, 2004 [PUBMED
abstract] |
| |
|
|
| |
2003 |
| |
|
|
| |
231.
|
Baidal
DA, Froud T, Ferreira JV, Khan A, Alejandro R, Ricordi
C: The bag method for islet cell infusion. Cell
Transplant 12:809-813, 2003 [PUBMED
abstract] |
| |
|
|
| |
232.
|
Desai
NM, Goss JA, Deng S, Wolf BA, Markmann E, Palanjian
M, Shock AP, Feliciano S, Brunicardi FC, Barker
CF, Naji A, Markmann JF: Elevated portal vein drug
levels of sirolimus and tacrolimus in islet transplant
recipients: local immunosuppression or islet toxicity?
Transplantation 76:1623-1625, 2003 [PUBMED
abstract] |
| |
|
|
| |
233. |
Kandeel,
Fouad; Smith, Craig V.; Todorov, Ivan; Mullen, Yoko: Advances in Islet Cell Biology:
From Stem Cell Differentiation to Clinical Transplantation: Conference Report. Pancreas.
27(3):e63-e78, October 2003.
[PUBMED] |
| |
| |
234.
|
Mahato
RI, Henry J, Narang AS, Sabek O, Fraga D, Kotb M,
Gaber AO: Cationic lipid and polymer-based gene
delivery to human pancreatic islets. Mol.Ther.
7:89-100, 2003 [PUBMED
abstract] |
| |
|
|
| |
235.
|
Markmann
JF, Deng S, Huang X, Desai NM, Velidedeoglu EH,
Lui C, Frank A, Markmann E, Palanjian M, Brayman
K, Wolf B, Bell E, Vitamaniuk M, Doliba N, Matschinsky
F, Barker CF, Naji A: Insulin independence following
isolated islet transplantation and single islet
infusions. Ann.Surg. 237:741-750, 2003 [PUBMED
abstract] |
| |
|
|
| |
236.
|
Markmann
JF, Rosen M, Siegelman ES, Soulen MC, Deng S, Barker
CF, Naji A: Magnetic resonance-defined periportal
steatosis following intraportal islet transplantation:
a functional footprint of islet graft survival?
Diabetes 52:1591-1594, 2003 [PUBMED
abstract] |
| |
|
|
| |
237.
|
Ricordi
C: Islet transplantation: a brave new world. Diabetes
52:1595-1603, 2003 [PUBMED
abstract] |
| |
|
|
| |
238.
|
Ritzel
RA, Veldhuis JD, Butler PC: Glucose stimulates pulsatile insulin secretion from human
pancreatic islets by increasing secretory burst mass; dose-response relationships. J
Clin Endocrinol Metab 2003 Feb. 88(2):724-747.
[PUBMED
abstract] |
| |
|
|
| |
239.
|
Ritzel
RA, Butler PC: Replication increases beta cell vulnerability to human islet amyloid
polypeptide induced apoptosis. Diabetes 2003. 52:1701-1708.
[PUBMED
abstract] |
| |
|
|
| |
240.
|
Robertson
RP, Kendall DM: Islet transplantation 2003: questions
about its future. Curr Opin Endocrinol Diabetes
10:128-132, 2003.
|
| |
|
|
| |
241.
|
Song
SH, Rhodes CJ, Veldhuis JD, Butler PC: Diazoxide attenuates glucose-induced defects
in first phase insulin release and pulsatile insulin secretion in human islets.
Endocrinology 2003 Aug. 144(8):3399-3405.
[PUBMED
abstract] |
| |
|
|
| |
2002 |
| |
|
|
| |
242.
|
Hering
BJ, Matsumoto I, Sawada T, Nakano M, Sakai T, Kandaswamy
R, Sutherland DE: Impact of two-layer pancreas preservation
on islet isolation and transplantation. Transplantation
74:1813-1816, 2002 [PUBMED
abstract] |
| |
| |
243.
|
Knazek
RA: The human pancreatic islet cell resource consortium.
Diabetes Technol.Ther. 4:551-552, 2002
[PUBMED
abstract] |
| |
|
|
| |
244.
|
Matsumoto
S, Qualley SA, Goel S, Hagman DK, Sweet IR, Poitout V,
Strong M, Robertson RP, Reems JA: Effect of the two-layer
[University of Wisconsin Solution (UW) / Perfluorochemical
(PFC) Plus 02] method of pancreas preservation on human
islet isolation as assessed by the Edmonton isolation
protocol1 Transplantation 74(10):1414-9,2002. PMID:
12451242
[PUBMED
abstract] |
| |
|
|
| |
245.
|
Paty
B, Ryan E, Shapiro AM, Lakey J, Robertson RP: Intrahepatic
islet transplantation in type 1 diabetic patients does
not restore hypoglycemic hormonal counterregulation or
symptom recognition after insulin independence.
Diabetes 51(12):3428-34, 2002.
[PUBMED
abstract] |
| |
|
|
| |
246.
|
Robertson
RP: Intrahepatically transplanted islets: Strangers
in a strange land. J Clin Endocrinol Metab 87(12):5416-7, 2002.
Full Text
|
| |
|
|
| |
247.
|
Song
SH, Kjems L, Ritzel R, McIntyre SM, Johnson ML, Veldhuis JD, Butler PC: Pulsatile
insulin secretion by human pancreatic islets. J Clin Endocrinol Metab 2002 Jan;87(1):213-21.
[PUBMED
abstract] |
| |
|
|
| |
248.
|
Sweet
IR, Khalil G, Wallen AR, Steedman M, Schenkman KA,
Reems JA, Kahn SE, Callis JB: Continuous measurement
of oxygen consumption by pancreatic islets. Diabetes
Technol.Ther.4:661-672, 2002 [PUBMED
abstract] |
| |
|
|
| |
249.
|
Tanaka
Y, Tran PO, Harmon J, Robertson RP: A role for glutathione
peroxidase in protecting pancreatic B cells against oxidative
stress in a model of glucose toxicity. Proc Natl Acad
Sci USA 99(19):12363-8, 2002. PMID: 12218186
[PUBMED
abstract] |
| |
|
|
| |
250.
|
Wang
DA, Narang AS, Kotb M, Gaber AO, Miller DD, Kim
SW, Mahato RI: Novel branched poly(ethylenimine)-cholesterol
water-soluble lipopolymers for gene delivery. Biomacromolecules.
3:1197-1207, 2002 [PUBMED
abstract] |
| |
|
|
Abstracts, Presentations
|
| |
2009 |
| |
|
|
| |
1.
|
Costes
S, Huang AC, Gurlo T, Daval M, Butler P: UCH-L1 deficiency may contribute to �-cell
defects in type 2 diabetes. Keystone Symposium "The Many Faces of Ubiquitin" Copper
Mountain, Colorado, January 11-16, 2009 Abstract #124.
|
| |
|
|
| |
2008 |
| |
|
|
| |
2.
|
Alonso,
L, Vasavada, R, Wang, L, Pascoe, J, Mellado-Gil, J, Rosa, T,
O�Donnell, C, Garcia-Ocana, A. Protein kinase C (PKC) z (zeta)
activation is essential for glucose-mediated �-cell proliferation..
First Annual Meeting of the Upper Midwest Islet Club,
April 29-May 2, 2008. [Presentation]
|
| |
|
|
| |
3.
|
Alonso
LC, Vasavada RC, Wang L, Pascoe J, Mellado-Gil JM, Rosa T, O'Donnell CP, Garcia-Oca�a
A: Protein kinase C (PKC) Zeta activation is essential for glucose-mediated �-cell proliferation.
Proceedings of the Keystone Symposium "Islet and Beta Cell Development and Transplantation", 2008. [Presentation]
|
| |
|
|
| |
4.
|
Balamurugan
AN, Velmurugan K and Pugazhenthi S. CREB-mediated protection
of human islets from apoptosis in culture and after
transplantation in streptozotocin-induced diabetic
athymic nude mice. Keystone Symposium on Islet and Beta Cell
Biology, Snowbird Utah, April 6-11 2008.
|
| |
|
|
| |
5.
|
Butler PC.
Beta cell mass; a therapeutic target or the cards you are
dealt? Keystone Symposium on Islet and Beta Cell Biology,
Snowbird Utah, April 6-11 2008 Abstract #029.
|
| |
|
|
| |
6.
|
Fiaschi-Taesch
N, Bigatel T, Sicara B, Takane KK, Stewart AF: Overexpression of cdk6, A human specific
beta cell cdk, induces human beta cell proliferation and promotes engraftment and function
of human islets. First Annual Meeting of the Upper Midwest Islet Club, April 29-May 2, 2008.
[Presentation]
|
| |
|
|
| |
7.
|
Ho
LT, Zebadua E, Kao P, Urrutia T, Orr C, Ferreri K, Kandeel F, Kuhtreiber W:
Secretion of injury factors by human islets after isolation and hypoxia. The
8thAnnual Rachmiel Levine Diabetes and Obesity Symposium January13-16, 2008.
|
| |
|
|
| |
8.
|
Hughes
KJ, Corbett JA: Repair of Pancreatic beta-cells from cytokine-mediated DNA damage.
First Annual Meeting of the Upper Midwest Islet Club, April 29-May 2, 2008. [Poster]
|
| |
|
|
| |
9.
|
Iglesias,
I Bentsi-Barnes, K, Umeadi, C, Brown, L, Wert, D, Spalla, C,
Kandeel, F, Al-Abdullah, IH. Flow and laser scanning cytometry
analysis of human pancreatic islets. The 8th Annual Rachmiel
Levine Diabetes and Obesity Symposium January 13-16, 2008.
|
| |
|
|
| |
10.
|
Kaddis,
J, Dajun, Q, Olack, B, Cravens, J, Antler, M, Ruel, N, Hanson,
M, Papas, K, Contreras, J, Fernanadez, L, Niland, J. Temperature
and Pressure changes during islet transport using a standardized
shipping container: A study by the National Islet Cell Resource
Center Consortium. The 8th Annual Rachmiel Levine Diabetes and
Obesity Symposium January 13-16, 2008.
|
| |
|
|
| |
11.
|
Kaestner
KH. Using functional genomics to identify targets for beta-cell
expansion. Keystone Symposium on Islet and Beta Cell Biology,
Snowbird Utah, April 6-11 2008 Abstract #005.
|
| |
|
|
| |
12.
|
Lavine,
JA, Raess, PW, Davis, DB, Presley, BK, Schueler, KL, Fernandez,
LA. Overexpression of cholecystokinin in isolated human islets
stimulates beta cell proliferation. First Annual Meeting of the
Upper Midwest Islet Club, April 29-May 2, 2008. [Presentation]
|
| |
|
|
| |
13.
|
Lei,
X, Zhang, S, Ramanadam, S. Ceramides and their role in ER
stress-induced beta cell death. Implications for T1DM. First
Annual Meeting of the Upper Midwest Islet Club, April 29-May 2, 2008.
|
| |
|
|
| |
14.
|
Liu
H, Remedi MS, Pappan KL, Kwon G, Rohatgi N, Marshall CA, McDaniel ML. Both
Glycogen Synthase Kinase-3 (GSK-3) and Mammalian Target of Rapamycin (mTOR)
Pathways Contribute to DNA Synthesis, Cell Cycle Progression and Proliferation
in Human Islets. Washington University in St. Louis Diabetes Research Training
Center Diabetes Day Symposium Nov 14, 2008. [Poster]
|
| |
|
|
| |
15.
|
Luo
L, Fang X, Ricordi C, Luo J. Human Islet Longevity: A
New Approach with Allogeneic Bone Marrow. 2008 Diabetes
57:Suppl.1 1596-P, A446
|
| |
|
|
| |
16.
|
Mellado-Gil
JM, Rosa T, Gonzalez-Pertusa JA, Demirci C, Garcia-Oca�a A: Hepatocyte growth factor
(HGF) receptor, c-Met is dispensable for normal β-cell growth and function but essential
for β-cell survival and proliferation in an animal model of type 1 diabetes. Proceedings
of the Keystone Symposium "Islet and Beta Cell Development and Transplantation", 2008.
[Presentation]
|
| |
|
|
| |
17.
|
Nair,
I, Todorov, I, Rawson, J, Shintaku, J, Valiente, L, Omori,
K, Kandeel, F, Mullen, Y. Islet grading using image analysis
A novel technique for islet quality assessment. The 8th Annual
Rachmiel Levine Diabetes and Obesity Symposium January 13-16,
2008.
|
| |
|
|
| |
18.
|
Niland
J: NIH funded Islet Resource Centers (ICR) program: Update. The 8thAnnual Rachmiel
Levine Diabetes and Obesity Symposium January13-16, 2008.
|
| |
|
|
| |
19.
|
Nunemaker
CS, Runpei WU, Kaiwen MA, Chakrabarti SK, Nadler JL: 12-Lipoxygenase Products Reduce
Insulin Secretion and Viability in Human Islets: A Possible Role of p38 MAPK. Presented
to American Diabetes Association, 2008. Abstract #1562-P.
|
| |
|
|
| |
20.
|
Ogihara,
T, Garmey, JC, Chuang, JC, Repa, JJ, Ketchum, RJ, Brayman,
KL, Mirmira, RG, Evans-Molina, Carmella. Liver X receptor
agonism augments glucose-stimulated insulin transcription
and secretion in human islets. First Annual Meeting of the
Upper Midwest Islet Club, April 29-May 2, 2008. [Presentation]
|
| |
|
|
| |
21.
|
Omori,
K Nair, Indu, Valiente, Luis, Todorov, I, Kanseel, F, Mullen,
Y. Validation of conventional manual counting of human islets
by semi-automated digital image analysis. The 8th Annual Rachmiel
Levine Diabetes and Obesity Symposium January 13-16, 2008.
|
| |
|
|
| |
22.
|
Rawson
J, Kandeel F, Mullen Y: An inherent problem with the non-diabetic NODscid mouse as an
in vivo model for isolated islet quality. The 8th Annual Rachmiel Levine Diabetes and
Obesity Symposium January 13-16, 2008.
|
| |
|
|
| |
23.
|
Shintaku,
J, Omori, K, Rawson, J Kandeel, F, Mullen, Y. Positive correlation
between ATP/ADP Ratio and glucose-stimulated insulin release of
cultured human islets. The 8th Annual Rachmiel Levine Diabetes
and Obesity Symposium January 13-16, 2008.
|
| |
|
|
| |
24.
|
Stewart,
AF. Molecular Control of the cell cycle in pancreatic beta
cells. The 8th Annual Rachmiel Levine Diabetes and Obesity
Symposium January 13-16, 2008.
|
| |
|
|
| |
25.
|
Thurmond
DC. Regulation of second-phase insulin secretion by Cdc-42,
Syntaxin 4 and Munc18c. Keystone Symposium on Islet and Beta
Cell Biology, Snowbird Utah, April 6-11 2008 Abstract #018.
|
| |
|
|
| |
26.
|
Weir,
G. The fate of transplanted islets exposed to hyperglycemia.
The 8th Annual Rachmiel Levine Diabetes and Obesity Symposium
January 13-16, 2008.
|
| |
|
|
| |
2007 |
| |
|
|
| |
27.
|
Al-sayed,
M, Al-Abdullah, I., Omori, K, Williams, B, Todorov, I
Ferrir, K, Ipp, E, Mullen, Y, Smith, Craig, Kandeel, F.
Improved graft survival following islet transplantation using
higher sirolimus levels. 2007 Joint Conference CTS-IPITA-IXA
September 15-20, 2007. [Presentation]
|
| |
|
|
| |
28. |
Asari
S, Itakura S, Rawson J, Ito T, Todorov I, Nair I, Liu CP, Kandeel
F, Mullen Y: Intervention of autoimmunity in NOD mice by co-transplantation
of allogeneic bone marrow cell and mesenchymal stem cells. Joint Conference
CTS-IPITA-IXA September 15-20, 2007.
|
| |
29.
|
Avgoustiniatos,
E, Hering B, Rozak, P, Wilson, J, Tempelman, L, Papas, K.
Commercially available gas-permeable bags may not prevent
anoxia in cultured or shipped islets. 2007 Joint Conference
CTS-IPITA-IXA September 15-20, 2007. [Presentation]
|
| |
|
|
| |
|
|
| |
30.
|
Bansal-Pakala,
P, Hire, K, Clemmings, S, Hering, B.HOKT3gamma Ala, Ala
induces higher treg frequencies in islet transplant patients
correlating with long-term graft survival. 2007 Joint Conference
CTS-IPITA-IXA September 15-20, 2007. [Presentation]
|
| |
|
|
| |
31.
|
Bansal-Pakala,
P, Hire, K, Sullivan, N, Ngo, Diem, Parkey, J, Hering, B.
Long-term islet allograft survival with increased CD4+CD25+FoxP3+Tregs in
type 1 diabetic recipients. 2007 Joint Conference CTS-IPITA-IXA
September 15-20, 2007. [Presentation]
|
| |
|
|
| |
232
|
Bigatel TA, Cozar-Castellano I, Velasquez S,
Harb G, Fiaschi-Taesch N, Selk K, Takane KK,
Stewart AF. Comprehensive Comparative Cell Cycle
Analysis Reveals Critical Differences Between Human
and Murine Beta Cell Cycle Regulation: Human Islets
Contain Cdk-6 But Lack Cdk-4. The 67th Annual Scientific
Sessions of the American Diabetes Association, June 22-26 2007.
|
| |
|
|
| |
33.
|
Bonner-Weir,
S. Beta cell regeneration. 2007 Joint Conference CTS-IPITA-IXA
September 15-20, 2007. [Presentation]
|
| |
|
|
| |
34.
|
Danobeitia,
J, Greenwood, K, Vijayan, Am Hanson, M, Odorico,
J, Fernandez, L. Quantitative and qualitative
comparison of the performance of Serva NB1 collagenase
and neutral protease with Liberase HI in the isolation
of human pancreatic islets. 2007 Joint Conference
CTS-IPITA-IXA September 15-20, 2007. [Presentation]
|
| |
|
|
| |
35.
|
Fernandez,
L. Pancreas donation after cardiac death. 2007 Joint
Conference CTS-IPITA-IXA September 15-20, 2007.
[Presentation]
|
| |
|
|
| |
36.
|
Fu
Z, Liu D. Phytochemical Genistein Promotes Beta
Cell Survival, Insulin Secretory Function and
Ameliorates Hyperglycemia in Streptozotocin
Induced Diabetic Mice. The 67th Annual Scientific
Sessions of the American Diabetes Association, June 22-26 2007.
|
| |
|
|
| |
37.
|
Garcia-Ocaña
A, Sipula D, Takane K, Bottino R, Trucco M,
Vasavada RC. Parathyroid hormone-related protein
(PTHrP) is a mitogen for human beta cells through
the PTH/PTHrP receptor. Proceedings of the 89th
Meeting of the Endocrine Society, 2007.
|
| |
|
|
| |
38.
|
Hanson,
M, Armann, B, Steffen, A, Sperger, J, Hullet, D,
Odorico, J, D'Alessandro, A, Sollinger, H, Fernandez,
L. Evaluation of islet quality from donation after
cardiac death using a novel extended quality control
assessment program. 2007 Joint Conference CTS-IPITA-IXA
September 15-20, 2007. [Presentation]
|
| |
|
|
| |
39.
|
Hanson,
M, Hullet, D, Sperger, J, Greenwood, K, Vijayan, A, Odorico,
J, Fernandez. L. Reducing islet transplant primary graft
non-function through implementation of an extended quality
control assessment program. 2007 Joint Conference CTS-IPITA-IXA
September 15-20, 2007. [Presentation]
|
| |
|
|
| |
40.
|
Hering,
B, Parkey, J, Kandaswamy, R, Jevne, R, Snead, D, Lervk, B,
Harmon, J, Tanaka, T,Yonekawa, Y Matsumoto, S. Analysis of
long-term silet allograft function in recipients given depleting
T-cell antibodies for induction immunosuppression. 2007 Joint
Conference CTS-IPITA-IXA September 15-20, 2007. [Presentation]
|
| |
|
|
| |
41.
|
Ichii
H, Yamamoto T, Sakuma Y, Miki A, Rodriguez R,
Inverardi L, Ricordi C. The effect of non-endocrine
cells on islet potency: Comparison between ADP/ATP ratio
and p-cell fractional viability. American Journal of
Transplantation, 7:205-206 227 Suppl. 2 May 2007.
|
| |
|
|
| |
42.
|
Inverardi,
L. Islet cytoprotection. 2007 Joint Conference
CTS-IPITA-IXA September 15-20, 2007. [Presentation]
|
| |
|
|
| |
43.
|
Linetsky,
E. Regulation challenges in manufacturing of
pancreatic islets. 2007 Joint Conference
CTS-IPITA-IXA September 15-20, 2007. [Presentation]
|
| |
|
|
| |
44.
|
Luo
L. Allogeneic Bone Marrow Repair Human Islet Damage: A New
Approach In Ex Vivo. Invited Lecture, Stem Cells For Diabetes
Therapy In Human Islet. Cellutions Summit August 16-19 2007,
Boston, Massachusetts.
|
| |
|
|
| |
45.
|
Naji,
A. Targeting beta cells. 2007 Joint Conference
CTS-IPITA-IXA September 15-20, 2007. [Presentation]
|
| |
|
|
| |
46.
|
Oberholzer,
J. The one step density gradient for human islet
purification. 2007 Joint Conference CTS-IPITA-IXA
September 15-20, 2007. [Presentation]
|
| |
|
|
| |
47.
|
Oberholzer,
J. Islet cells. 2007 Joint Conference CTS-IPITA-IXA
September 15-20, 2007. [Presentation]
|
| |
|
|
| |
48. |
Omori
K, Shintaku J, Rawson J, Todorov I, Nair I, Al-Abdullah I, Higgins
L, Medicherla S, Kandeel F, Mullen Y: p38 mitogen activated
protein kinase inhibitor improves the quality of cultured human islets.
Joint Meeting of the International Xenotransplantation, the International
Pancreas and Islet Transplantation Association, and the Cell Transplantation
Society, Sept. 2007, 14, p420 #307.9
|
| |
|
|
| |
49.
|
Omori
K, Shintaku J, Rawson J, Todorov I, Nair I, Al-Abdullah I, Higgins L: P38 mitogen
activated protein kinase inhibitor (p38IH) improves the quality of cultured human
islets. 2007 Joint Conference CTS-IPITA-IXA September 15-20, 2007. [Presentation]
|
| |
|
|
| |
50.
|
Papas,
K. New approaches to pancreas preservation. 2007
Joint Conference CTS-IPITA-IXA September 15-20,
2007. [Presentation]
|
| |
|
|
| |
51.
|
Papas,
K. New equipment for islet culture and shipment.
2007 Joint Conference CTS-IPITA-IXA September 15-20,
2007. [Presentation]
|
| |
|
|
| |
52.
|
Pappan
KL, Liu H, Remedi MS, Marshall CA, Kwon G, McDaniel ML: Glycogen synthase kinase
(GSK-3) signaling to mammalian target of rapamycin (mTOR) regulates DNA synthesis
and cell cycle progression in rodent and human islets. Diabetes 2007 56 S1 1755-P
ADA 67th Scientific Sessions. [Abstract]
|
| |
|
|
| |
53.
|
Rickels,
M, Mueller, R, Markmann, J, Naji, A. Effect of
GLP-1 on β- and α cell function in isolated islet
and whole pancreas transplant recipients. 2007 Joint
Conference CTS-IPITA-IXA September 15-20, 2007.
[Presentation]
|
| |
|
|
| |
54.
|
Ricordi,
C. Enzymes for human isolation - How I do it. 2007
Joint Conference CTS-IPITA-IXA September 15-20, 2007.
[Presentation]
|
| |
|
|
| |
55.
|
Ricordi,
C. New equipment for islet processing. 2007
Joint Conference CTS-IPITA-IXA September 15-20,
2007. [Presentation]
|
| |
|
|
| |
56.
|
Salehi,
P, Barbaro, B, Wang, Y, Qi, M, Gangemi, A, Kuechle, J,
Hansen, M, Benedetti, E, Mage, R, Oberholzer, J. Improved
human pancreatic islet purification using the refined UIC-UB
density gradient. 2007 Joint Conference CTS-IPITA-IXA
September 15-20, 2007. [Presentation]
|
| |
|
|
| |
2006 |
| |
|
|
| |
57.
|
Klein D,
Barbe-Tuana F, Berman-Weinberg D, Kenyon NS,
Ricordi C, Pastori RL. CD40-CD40L Interaction Activates
Pro-Inflamatory Pathways In Pancreatic Islets. World
Transplant Congress Boston MA, July 2006.
|
| |
|
|
| |
58.
|
Zhang
W, Liu D. Genistein Induces Pancreatic Beta-Cell
Proliferation through the Cyclic AMP Dependent Protein
Kinase and MEK/ERK Signaling Pathways. The 66th Annual
Scientific Sessions of the American Diabetes Association,
June 9-13 2006.
|
| |
|
|
| |
2005 |
| |
|
|
| |
59.
|
Barbe-Tuana
F, Klein D, Ichii H, Escalona M, Berman-Weinberg D,
Kenyon NS, Ricordi C, Pastori R.L. Proinflammatory
Pathway Activation through CD40 in Human and Non Human
Primate Islet Cells. Late-Breaking Research Abstracts.
American Diabetes Association. 65th Scientific Sessions,
San Diego, California, June 2005
|
| |
|
|
| |
2004 |
| |
|
|
| |
60.
|
Barbe-Tuana,
F., Klein D., Pugliese, A., Ichii, H., Gonzalez, M., Molano,
R.D., Ricordi, C., Pastori, R.L. Expression of CD40 in
pancreatic beta cells. The Cell Transplant Society 7th
International Congress November 2004, Boston, USA
|
| |
|
|
| |
61.
|
Fenjves
ES, Gay-Rabinstein C, Ochoa MS, et al. Human
pancreatic islets genetically engineered using
a bicistronic lentiviral vector: Implications
for islet transplantation. Presented to Cell
Transplantation Society, Boston MA, November 2004.
|
| |
|
|
| |
62.
|
Fenjves
ES, Ochoa MS, Gay-Rabinstein C, et al. Delivery of two
genes to human pancreatic islets using a bicistronic
feline immunodeficiency viral vector improves islet
viability; implications for enhancing islet transplantation.
Presented to American Diabetes Association,
64th Scientific Sessions, Orlando Florida, June 4-8 2004.
|
| |
|
|
| |
63.
|
Fenjves
ES, Ochoa MS, Gay-Rabinstein C, et al. Transduction
of human pancreatic islets using a bicistronic feline
immunodeficiency viral vector; implications for islet
transplantation. Presented to American Transplant
Congress, Boston MA, May14-19 2004.
|
| |
|
|
| |
64.
|
Mendoza V,
Klein D, Ichii H, Ricordi C, and Pastori, RL. Protection
of islets in culture by delivery of oxygen binding
neuroglobin via protein transduction. XX International
Congress of the Transplantation Society, Vienna September 2004.
|
| |
|
|
| |
|
|
| |
IF
you are aware of any publication(s) which should
be listed here, but is not, please contact [email protected].
|
|
|
|
|
|
